haloperidol has been researched along with Neuroleptic Malignant Syndrome in 221 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
Neuroleptic Malignant Syndrome: A potentially fatal syndrome associated primarily with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS) which are in turn associated with dopaminergic receptor blockade (see RECEPTORS, DOPAMINE) in the BASAL GANGLIA and HYPOTHALAMUS, and sympathetic dysregulation. Clinical features include diffuse MUSCLE RIGIDITY; TREMOR; high FEVER; diaphoresis; labile blood pressure; cognitive dysfunction; and autonomic disturbances. Serum CPK level elevation and a leukocytosis may also be present. (From Adams et al., Principles of Neurology, 6th ed, p1199; Psychiatr Serv 1998 Sep;49(9):1163-72)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Haloperidol, which is commonly used to treat agitation in critically ill patients, has been associated with the development of neuroleptic malignant syndrome (NMS)." | 8.85 | Neuroleptic malignant syndrome in traumatic brain injury patients treated with haloperidol. ( Bellamy, CJ; Falcione, BA; Kane-Gill, SL; Seybert, AL, 2009) |
| "The frequency of neuroleptic malignant syndrome (NMS) after clozapine or olanzapine is low and often of non-serious nature." | 8.82 | [Life threatening neuroleptic malignant syndrome due to olanzapine]. ( Becker, T; Kopf, A; Köster, J; Krömker, H; Schulz, A, 2003) |
| "A 6-year-old severely handicapped boy with haloperidol-induced mild rhabdomyolysis without neuroleptic malignant syndrome is reported." | 8.80 | Haloperidol-induced rhabdomyolysis without neuroleptic malignant syndrome in a handicapped child. ( Abe, T; Oda, Y; Ozawa, K; Watanabe, T; Yoshikawa, H, 2000) |
| "The paper reports on a rare case of fulminant neuroleptic malignant syndrome (NMS) with several risk factors, typical manifestation and rapid death induced by low doses of haloperidol." | 7.80 | Death due to fulminant neuroleptic malignant syndrome induced by low doses of haloperidol: a rare case. ( Chen, Y; Huang, P; Li, Z; Liu, N; Qin, Z; Shao, Y; Zhang, J; Zou, D, 2014) |
| "The authors report a case of a patient, who in a few days after an abrupt discontinuation of clozapine and haloperidol developed agitated and confused state resembling neuroleptic malignant syndrome (NMS) and clozapine withdrawal symptoms at the same time." | 7.73 | Neuroleptic malignant syndrome and clozapine withdrawal at the same time? ( Aukst-Margetić, B; Margetić, B, 2005) |
| "This case report describes a terminally ill patient with cancer with severe hypophosphataemia, hypocalcemia, and hypomagnesemia who developed neuroleptic malignant syndrome after administration of a combination of haloperidol and fentanyl." | 7.72 | Neuroleptic malignant syndrome after haloperidol and fentanyl infusion in a patient with cancer with severe mineral imbalance. ( Inoue, S; Morita, T; Nagayama, K; Shishido, H; Tei, Y, 2004) |
| "To report a case of neuroleptic malignant syndrome (NMS) in a patient whose therapy was being switched from haloperidol to risperidone." | 7.71 | Neuroleptic malignant syndrome during a change from haloperidol to risperidone. ( Mack, JE; Reeves, RR; Torres, RA, 2001) |
| " The following case report describes a patient developing neuroleptic malignant syndrome (NMS) secondary to the use of haloperidol given to control the patient's agitation." | 7.70 | Neuroleptic malignant syndrome induced by haloperidol following traumatic brain injury. ( Guin-Renfroe, S; Meythaler, JM; Wilkinson, R, 1999) |
| "A patient with chronic schizophrenia, who had been treated for a long time with chlorpromazine, haloperidol, levodopa, benserazide hydrochloride, diazepam and biperiden, developed extreme hypothermia (about 32 degrees C) when the dose of haloperidol was increased because of a deterioration of the patient's mental symptoms." | 7.69 | A schizophrenic patient who developed extreme hypothermia after an increase in the dose of haloperidol: a case report. ( Harada, H; Igarashi, M; Nakajima, T; Okamoto, K; Sugae, S; Tsuji, M, 1994) |
| " Experimental rabbits treated with haloperidol (1 mg/kg) by intramuscular injection, were studied for the diagnostic symptoms of increased muscle rigidity, elevated body temperature, and high serum creatine phosphokinase (CPK) level." | 7.69 | Development of an animal model for neuroleptic malignant syndrome: heat-exposed rabbits with haloperidol and atropine administration exhibit increased muscle activity, hyperthermia, and high serum creatine phosphokinase level. ( Hosono, T; Ikura, Y; Kudo, T; Niigawa, H; Nishimura, T; Sakamoto, S; Takeda, M; Taniguchi, N; Tanii, H, 1996) |
| "We describe the second reported case of neuroleptic malignant syndrome (NMS) related to tetrabenazine therapy in Huntington's disease." | 7.68 | Neuroleptic malignant syndrome related to tetrabenazine introduction and haloperidol discontinuation in Huntington's disease. ( Giménez-Roldán, S; Mateo, D; Muñoz-Blanco, JL, 1992) |
| "A 31-year-old man with psychosis and neuroleptic-induced tardive dystonia developed neuroleptic malignant syndrome (NMS) while taking haloperidol." | 7.67 | Neuroleptic malignant syndrome responsive to carbidopa/levodopa: support for a dopaminergic pathogenesis. ( Harris, M; Nora, L; Tanner, CM, 1987) |
| "Neuroleptic malignant syndrome is a rare neuropsychiatric complication caused by antipsychotic drugs." | 5.72 | [Neuroleptic malignant syndrome caused by olanzapine, risperidone and haloperidol]. ( Boesen, MS; Ladefoged, MR; Marloth, PV, 2022) |
| "Haloperidol was initiated at 5 mg intravenous every 6 h and titrated up to a dose of 60 mg /day over 5 days." | 5.39 | Neuroleptic malignant syndrome associated with haloperidol use in critical care setting: should haloperidol still be considered the drug of choice for the management of delirium in the critical care setting? ( Adelman, M; Dixit, D; Shrestha, P, 2013) |
| "Haloperidol was stopped and intravenous clonazepam 5mg/kg was begun." | 5.36 | [Catatonia in a 14 year-old girl: treatment with clorazepam and carbamazepine, a 10-year follow-up]. ( Askenazy, F; Benoit, M; Dor, E; Dupuis, G; Myquel, M; Seddiki, Y; Serret, S, 2010) |
| "A 34-year-old woman treated for a major depressive disorder experienced NMS with a phenothiazine." | 5.30 | Carbamazepine in the treatment of neuroleptic malignant syndrome. ( Cottencin, O; Goudemand, M; Maron, M; Rascle, C; Thomas, P; Vaiva, G, 1998) |
| "A case of neuroleptic malignant syndrome (NMS) in a 64-year-old man with cancer of the soft palate is reported." | 5.30 | Neuroleptic malignant syndrome during haloperidol treatment in a cancer patient. A case report. ( Akechi, T; Hayashi, R; Nishiwaki, Y; Tanaka, K; Uchitomi, Y; Yamazaki, M, 1998) |
| "Cocaine-related rhabdomyolysis has a high mortality." | 5.29 | Rhabdomyolysis and hyperthermia after cocaine abuse: a variant of the neuroleptic malignant syndrome? ( Daras, M; Kakkouras, L; Koppel, BS; Tuchman, AJ, 1995) |
| "This case comes into the so-called neuroleptic malignant syndrome which can rarely arise in patients treated with antipsycotic agents and which causes high mortality, particularly when there are rhabdomyolysis and acute renal failure." | 5.29 | [Rhabdomyolysis and acute renal failure caused by haloperidol-decanoate (neuroleptic malignant syndrome)]. ( Benati, F; Cesario, V; Lazzarin, M, 1996) |
| "This suggests that neuroleptic malignant syndrome is caused by a peripheral, not central, effect of haloperidol." | 5.28 | Fatal hyperthermia in a quadriplegic man. Possible evidence for a peripheral action of haloperidol in neuroleptic malignant syndrome. ( Downey, JA; Downey, RJ; Newhouse, E; Weissman, C, 1992) |
| "This article describes a patient with lethal catatonia: treatment by ECT alone was ineffective, whereas continued treatment with ECT in combination with dantrolene sodium led to improvement." | 5.28 | Treatment of lethal catatonia with electroconvulsive therapy and dantrolene sodium: a case report. ( Nolen, WA; Zwaan, WA, 1990) |
| "Two typical recurrent episodes of neuroleptic malignant syndrome (NMS) in the same patient are described." | 5.27 | Recurrent neuroleptic malignant syndrome due to tiapride and haloperidol: the possible role of D-2 dopamine receptors. ( Hermesh, H; Huberman, M; Kott, E; Radvan, H, 1984) |
| "A case of neuroleptic malignant syndrome (NMS) with an abrupt onset was terminated quickly with i." | 5.27 | Resolution of neuroleptic malignant syndrome with dantrolene sodium: case report. ( Jaffe, JH; Khan, A; Morrison, B; Nelson, WH, 1985) |
| " The first group (n = 120) suffered from schizophrenia and was treated only with haloperidol." | 5.07 | Risk for definite neuroleptic malignant syndrome. A prospective study in 223 consecutive in-patients. ( Aizenberg, D; Hermesh, H; Lapidot, M; Mayor, C; Munitz, H; Weizman, A, 1992) |
| "Haloperidol, which is commonly used to treat agitation in critically ill patients, has been associated with the development of neuroleptic malignant syndrome (NMS)." | 4.85 | Neuroleptic malignant syndrome in traumatic brain injury patients treated with haloperidol. ( Bellamy, CJ; Falcione, BA; Kane-Gill, SL; Seybert, AL, 2009) |
| "The frequency of neuroleptic malignant syndrome (NMS) after clozapine or olanzapine is low and often of non-serious nature." | 4.82 | [Life threatening neuroleptic malignant syndrome due to olanzapine]. ( Becker, T; Kopf, A; Köster, J; Krömker, H; Schulz, A, 2003) |
| "A 6-year-old severely handicapped boy with haloperidol-induced mild rhabdomyolysis without neuroleptic malignant syndrome is reported." | 4.80 | Haloperidol-induced rhabdomyolysis without neuroleptic malignant syndrome in a handicapped child. ( Abe, T; Oda, Y; Ozawa, K; Watanabe, T; Yoshikawa, H, 2000) |
| "Neuroleptic-induced catatonia is reported in an adolescent patient who responded successfully to lorazepam." | 4.78 | Neuroleptic-induced catatonia as a stage in the progression toward neuroleptic malignant syndrome. ( Woodbury, MA; Woodbury, MM, 1992) |
| "The paper reports on a rare case of fulminant neuroleptic malignant syndrome (NMS) with several risk factors, typical manifestation and rapid death induced by low doses of haloperidol." | 3.80 | Death due to fulminant neuroleptic malignant syndrome induced by low doses of haloperidol: a rare case. ( Chen, Y; Huang, P; Li, Z; Liu, N; Qin, Z; Shao, Y; Zhang, J; Zou, D, 2014) |
| " Following initial improvement, she developed delayed rhabdomyolysis then haloperidol-induced neuroleptic malignant syndrome, which was treated with a total of 50 mg." | 3.78 | Ecstacy-induced delayed rhabdomyolysis and neuroleptic malignant syndrome in a patient with a novel variant in the ryanodine receptor type 1 gene. ( Hawryluck, LA; Kraeva, N; Riazi, S; Russell, T; Steel, AC, 2012) |
| " The Naranjo probability scale indicated probable causality for NMS due to quetiapine, haloperidol, and risperidone in this patient, whereas the Naranjo scale assigned only possible causality for serotonin syndrome developing with serotonergic agents." | 3.77 | Neuroleptic malignant syndrome versus serotonin syndrome: the search for a diagnostic tool. ( Ariano, RE; Sokoro, AA; Zivot, J, 2011) |
| "The authors report a case of a patient, who in a few days after an abrupt discontinuation of clozapine and haloperidol developed agitated and confused state resembling neuroleptic malignant syndrome (NMS) and clozapine withdrawal symptoms at the same time." | 3.73 | Neuroleptic malignant syndrome and clozapine withdrawal at the same time? ( Aukst-Margetić, B; Margetić, B, 2005) |
| "This case report describes a terminally ill patient with cancer with severe hypophosphataemia, hypocalcemia, and hypomagnesemia who developed neuroleptic malignant syndrome after administration of a combination of haloperidol and fentanyl." | 3.72 | Neuroleptic malignant syndrome after haloperidol and fentanyl infusion in a patient with cancer with severe mineral imbalance. ( Inoue, S; Morita, T; Nagayama, K; Shishido, H; Tei, Y, 2004) |
| "Neuroleptic malignant syndrome occurred in a 71-year-old man on haloperidol therapy for mild depressive dementia." | 3.71 | Neuroleptic malignant syndrome: uncommon postoperative diagnostic dilemma. ( Bhan, S; Kulkarni, V; Mehta, Y; Sharma, KK; Suri, ML; Trehan, N, 2002) |
| "To report a case of neuroleptic malignant syndrome (NMS) in a patient whose therapy was being switched from haloperidol to risperidone." | 3.71 | Neuroleptic malignant syndrome during a change from haloperidol to risperidone. ( Mack, JE; Reeves, RR; Torres, RA, 2001) |
| "We report four cases of neuroleptic malignant syndrome occurring after administration of a typical antipsychotic haloperidol and a newer atypical antipsychotic clozapine." | 3.70 | Neuroleptic malignant syndrome: an experience of four cases. ( Agarwal, A; Desai, ND; Diwan, PJ; Gore, YS; Jain, V; Jaydeokar, SS; Manocha, SM; Moulick, ND; Mundra, VK; Sutharsan, R, 1998) |
| " The following case report describes a patient developing neuroleptic malignant syndrome (NMS) secondary to the use of haloperidol given to control the patient's agitation." | 3.70 | Neuroleptic malignant syndrome induced by haloperidol following traumatic brain injury. ( Guin-Renfroe, S; Meythaler, JM; Wilkinson, R, 1999) |
| " Haloperidol is a drug used in the management of several psychotic disorders and its use has been linked to Neuroleptic Malignant Syndrome." | 3.70 | Methyl p-hydroxybenzoate (E-218) a preservative for drugs and food is an activator of the ryanodine receptor Ca(2+) release channel. ( Babini, E; Cavagna, D; Prestipino, G; Treves, S; Zorzato, F, 2000) |
| "The case of a 40 year old female patient of SLE who developed fatal neuroleptic malignant syndrome following administration of serenase (haloperidol) is reported." | 3.70 | Neuroleptic malignant syndrome occurring in a suspected case of systemic lupus erythematosus. ( Balakrishnan, C; Gohar, S; Joshi, VR; Mangat, G; Mittal, G; Sule, A, 2000) |
| "A patient with chronic schizophrenia, who had been treated for a long time with chlorpromazine, haloperidol, levodopa, benserazide hydrochloride, diazepam and biperiden, developed extreme hypothermia (about 32 degrees C) when the dose of haloperidol was increased because of a deterioration of the patient's mental symptoms." | 3.69 | A schizophrenic patient who developed extreme hypothermia after an increase in the dose of haloperidol: a case report. ( Harada, H; Igarashi, M; Nakajima, T; Okamoto, K; Sugae, S; Tsuji, M, 1994) |
| "We report a fulminant case of Neuroleptic Malignant Syndrome in a 31-year-old male schizophrenic on haloperidol, thioridazine, benzhexol and flurazepam who presented with rigidity, fever, stupor and autonomic instability." | 3.69 | A fulminant case of neuroleptic malignant syndrome. ( Chew, WL; Lam, KN; Teo, SK, 1994) |
| "Neuroleptic malignant syndrome was diagnosed in a 27-year-old pregnant female with a psychiatric disorder, after treatment with haloperidol." | 3.69 | [Successful electroconvulsive therapy in a pregnant woman with neuroleptic malignant syndrome]. ( Bosch, FH; Heinis, C; Thies, JE; Verwey, B; Verwiel, JM, 1994) |
| " Experimental rabbits treated with haloperidol (1 mg/kg) by intramuscular injection, were studied for the diagnostic symptoms of increased muscle rigidity, elevated body temperature, and high serum creatine phosphokinase (CPK) level." | 3.69 | Development of an animal model for neuroleptic malignant syndrome: heat-exposed rabbits with haloperidol and atropine administration exhibit increased muscle activity, hyperthermia, and high serum creatine phosphokinase level. ( Hosono, T; Ikura, Y; Kudo, T; Niigawa, H; Nishimura, T; Sakamoto, S; Takeda, M; Taniguchi, N; Tanii, H, 1996) |
| "A 50-year-old man presented with hyperosmolar non-ketotic diabetic coma associated with the neuroleptic malignant syndrome (NMS) after intramuscular treatment with haloperidol." | 3.68 | Neuroleptic malignant syndrome presenting as hyperosmolar non-ketotic diabetic coma. ( Balzan, M; Cacciottolo, JM, 1992) |
| "We describe the second reported case of neuroleptic malignant syndrome (NMS) related to tetrabenazine therapy in Huntington's disease." | 3.68 | Neuroleptic malignant syndrome related to tetrabenazine introduction and haloperidol discontinuation in Huntington's disease. ( Giménez-Roldán, S; Mateo, D; Muñoz-Blanco, JL, 1992) |
| "An adult schizophrenic patient developed neuroleptic malignant syndrome following treatment with parenteral haloperidol." | 3.68 | Neuroleptic malignant syndrome (a case report). ( Patkar, AA; Shah, LP, 1991) |
| "A 19-year-old man suffering from a first episode of schizophrenia developed a neuroleptic malignant syndrome (NMS) after administration of haloperidol and levomepromazine." | 3.68 | Low melanin content of substantia nigra in a case of neuroleptic malignant syndrome. ( Gertz, HJ; Schmidt, LG, 1991) |
| "Presented is a case report of a multiple trauma patient whose post-traumatic course was complicated by neuroleptic malignant syndrome triggered by therapeutic haloperidol treatments." | 3.67 | Neuroleptic malignant syndrome in a trauma patient: case report. ( Agarwal, NN; Heird, SB; Rhoads, JE, 1989) |
| "During treatment with clomipramine and haloperidol, a 54-year-old depressed woman exhibited a typical neuroleptic malignant syndrome (NMS)." | 3.67 | Central dopaminergic and noradrenergic receptor blockade in a patient with neuroleptic malignant syndrome. ( Ansseau, M; Dresse, AE; Franck, G; Kupfer, DJ; Poncelet, PF; Reynolds, CF; Reznik, M, 1986) |
| "A 31-year-old man with psychosis and neuroleptic-induced tardive dystonia developed neuroleptic malignant syndrome (NMS) while taking haloperidol." | 3.67 | Neuroleptic malignant syndrome responsive to carbidopa/levodopa: support for a dopaminergic pathogenesis. ( Harris, M; Nora, L; Tanner, CM, 1987) |
| " This constellation of symptoms, known as the neuroleptic malignant syndrome (NMS), partially improved when the neuroleptic medication was stopped, but complete resolution of the syndrome did not occur until the patient was treated with bromocriptine." | 3.67 | Neuroleptic malignant syndrome complicating closed head injury. ( Van Haren, J; Vincent, FM; Zimmerman, JE, 1986) |
| "We present the case of a 35-year-old man who developed symptoms of the neuroleptic malignant syndrome (NMS) after taking prescribed, moderately high, therapeutic doses of haloperidol." | 3.67 | Neuroleptic malignant syndrome. ( Lucid, EJ; Martin, ML; Walker, RW, 1985) |
| "Haloperidol was also associated with a significant increase of peripheral blood mononuclear cell membrane peroxidation." | 2.73 | Neuroleptic treatment effect on mitochondrial electron transport chain: peripheral blood mononuclear cells analysis in psychotic patients. ( Bernardo, M; Cardellach, F; Casademont, J; Garrabou, G; López, S; Miró, O; Pons, A, 2007) |
| "Eleven patients with various cancer types from ten case reports published from 1988 to 2013 met the eligibility criteria." | 2.66 | Neuroleptic malignant syndrome in patients with cancer: a systematic review. ( Ishida, M; Kawakami, K; Kawanishi, C; Onishi, H; Sato, I; Yamada, S, 2020) |
| "A diagnosis of neuroleptic malignant syndrome was made and the patient continued to receive aggressive supportive care." | 2.41 | Neuroleptic malignant syndrome and severe thrombocytopenia: case report and literature review. ( Ahmed, W; Ghani, SO; Marco, LA, 2000) |
| "Neuroleptic malignant syndrome is a rare but potentially fatal complication of treatment with antipsychotic medications." | 2.41 | Neuroleptic malignant syndrome in children and adolescents. ( Rothner, AD; Ty, EB, 2001) |
| "Neuroleptic malignant syndrome is a rare complication of antipsychotic medications." | 2.39 | Neuroleptic malignant syndrome in a trauma patient. ( Burke, C; Castellano, J; Fulda, GJ, 1995) |
| "Recently, some cases of neuroleptic malignant syndrome (NMS) in demented patients have been reported, because the demented patients, who were administered neuroleptics due to their abnormal behaviors, have increased." | 2.39 | [Clinical study of neuroleptic malignant syndrome in demented patients--examination of our case and reported cases]. ( Kimura, T; Yoshida, H, 1994) |
| "Neuroleptic malignant syndrome is difficult to distinguish from febrile catatonia and the diagnosis can often only be made through the clinical course." | 2.39 | [The neuroleptic malignant syndrome]. ( Agelink, MW; Dammers, S; Leonhardt, M; Schär, V; Zeit, T, 1995) |
| "Haloperidol was administered for agitation while the patient was in the intensive care unit." | 2.38 | Neuroleptic malignant syndrome in the intensive care unit. ( Branas, CC; Marino, PL; Sing, RF, 1993) |
| "The estimated incidence rate of neuroleptic malignant syndrome is between 1% and 1." | 2.38 | Neuroleptic malignant syndrome. ( Farooque, AI; Jahan, MS; Wahid, Z, 1992) |
| "A patient with neuroleptic malignant syndrome is reported." | 2.37 | Neuroleptic malignant syndrome: case report and review. ( Fernando, N; Hosford, I; Miller, M, 1988) |
| "Suspecting neuroleptic malignant syndrome, dantrolene sodium was administered along with symptomatic treatment with mechanical ventilation and cooling." | 1.42 | [A Case of Neuroleptic Malignant Syndrome Associated with Undiagnosed Dementia with Lewy Bodies]. ( Fukuda, M; Komasawa, N; Minami, T; Nishihara, I; Oka, M, 2015) |
| "Haloperidol was initiated at 5 mg intravenous every 6 h and titrated up to a dose of 60 mg /day over 5 days." | 1.39 | Neuroleptic malignant syndrome associated with haloperidol use in critical care setting: should haloperidol still be considered the drug of choice for the management of delirium in the critical care setting? ( Adelman, M; Dixit, D; Shrestha, P, 2013) |
| "Risperidone was discontinued and, owing to ongoing psychosis, olanzapine was initiated." | 1.38 | Antipsychotics leading to neuroleptic malignant syndrome in pregnancy. ( Aghajanian, P; Dossett, E; Ghaffari, N; Lee, RH, 2012) |
| "Haloperidol was stopped and intravenous clonazepam 5mg/kg was begun." | 1.36 | [Catatonia in a 14 year-old girl: treatment with clorazepam and carbamazepine, a 10-year follow-up]. ( Askenazy, F; Benoit, M; Dor, E; Dupuis, G; Myquel, M; Seddiki, Y; Serret, S, 2010) |
| "Thus, physician should consider catatonia when treating neuroleptic malignant like syndrome." | 1.36 | [Case with difficulty in differentiating between transient neuroleptic malignant syndrome and catatonia after neuroleptic analgesia]. ( Miyazaki, M; Yanagawa, Y, 2010) |
| "Five days after surgery, Neuroleptic Malignant Syndrome was diagnosed." | 1.35 | Neuroleptic malignant syndrome and cardiac surgery. A case report. ( Sirois, F, 2008) |
| "The treatment with haloperidol more often results in movement disorders, sleepiness, inhibition, sexual dysfunction and cholinolytic effects." | 1.35 | [Peculiarities of neuroleptic syndrome in women treated with typical and atypical neuroleptics]. ( Chitaia, NN; Danilov, DS; Tiuvina, NA, 2009) |
| "We report a case of severe neuroleptic malignant syndrome with hyperthermia, rhabdomyolysis and hepatic failure where we applied endovascular cooling in order to reverse hyperthermia." | 1.35 | Endovascular cooling in a patient with neuroleptic malignant syndrome. ( Diedler, J; Mellado, P; Veltkamp, R, 2008) |
| "The autopsy established the diagnosis of progressive supranuclear palsy (PSP)." | 1.34 | Undiagnosed progressive supranuclear palsy in a patient with neuroleptic malignant syndrome due to use of neuroleptics: the utility of autopsy in deaths due to known drug reactions. ( Fitzgerald, J; Kemp, WL; White, CL, 2007) |
| "Neuroleptic malignant syndrome is a rare disorder that manifests with hyperthermia, muscle rigidity and autonomic instability." | 1.32 | Early recognition of neuroleptic malignant syndrome during traumatic brain injury rehabilitation. ( Colachis, SC; Depalma, MJ; Kadyan, V; Mysiw, WJ; Sanderson, JD, 2003) |
| "Bromperidol 12 mg was prescribed to treat his symptoms." | 1.31 | [Malignant syndrome caused by a combination of bromperidol and donepezil hydrochloride in a patient with probable dementia with Lewy bodies]. ( Iwado, H; Morita, Y; Shinjo, H; Ueki, A, 2001) |
| "Neuroleptic malignant syndrome is a severe and potentially fatal reaction to neuroleptic drugs." | 1.30 | Plasmapheresis in neuroleptic malignant syndrome. ( Beny, A; Fradis, M; Gaitini, L; Krimerman, S; Vaida, S, 1997) |
| "A 34-year-old woman treated for a major depressive disorder experienced NMS with a phenothiazine." | 1.30 | Carbamazepine in the treatment of neuroleptic malignant syndrome. ( Cottencin, O; Goudemand, M; Maron, M; Rascle, C; Thomas, P; Vaiva, G, 1998) |
| " In this case, NMS seemed to be induced by bacterial pneumonia after long term administration of LPZ 5 mg per day." | 1.30 | [A study of neuroleptic malignant syndrome in the presenium and senium]. ( Honma, H; Koyama, T; Matsubara, S; Suzuki, I; Watanabe, N, 1998) |
| "A case of neuroleptic malignant syndrome (NMS) in a 64-year-old man with cancer of the soft palate is reported." | 1.30 | Neuroleptic malignant syndrome during haloperidol treatment in a cancer patient. A case report. ( Akechi, T; Hayashi, R; Nishiwaki, Y; Tanaka, K; Uchitomi, Y; Yamazaki, M, 1998) |
| "We report five cases of neuroleptic malignant syndrome (NMS) with psychotic symptoms treated with electroconvulsive therapy (ECT)." | 1.30 | Electroconvulsive therapy for the treatment of neuroleptic malignant syndrome with psychotic symptoms: a report of five cases. ( Ishiguro, T; Nisijima, K, 1999) |
| "We report a case of neuroleptic malignant syndrome associated with reversible leukoencephalopathy." | 1.30 | [A case of neuroleptic malignant syndrome associated with reversible leukoencephalopathy]. ( Shindou, K; Shiozawa, Z; Sugimoto, T; Tsunoda, S, 1999) |
| "Cocaine-related rhabdomyolysis has a high mortality." | 1.29 | Rhabdomyolysis and hyperthermia after cocaine abuse: a variant of the neuroleptic malignant syndrome? ( Daras, M; Kakkouras, L; Koppel, BS; Tuchman, AJ, 1995) |
| "A related syndrome, Malignant Hyperthermia (MH), is sometimes associated with central core disease." | 1.29 | Hyperthermic reaction to haloperidol with rigidity, associated to central core disease. ( Calore, EE; Cavaliere, MJ; Perez, NM; Razzouk, D; Russo, DH; Wakamatsu, A, 1994) |
| "The relationship between NMS and catatonia and possible therapeutic decisions are discussed." | 1.29 | Neuroleptic malignant syndrome and catatonia. A report of three cases. ( Altavista, MC; Cavallari, S; Lubich, L; Raja, M, 1994) |
| "We report a case of neuroleptic malignant syndrome where the catatonia clearly followed the administration of neuroleptics and where the neurovegetative disturbance was remarkably severe, including episodes of tracheal spasm, apnoea and episodes of bradycardia, and sinus arrest requiring insertion of a temporary external pacing wire." | 1.29 | Recurrent sinus arrest in association with neuroleptic malignant syndrome. ( Hamlin, GW; Ormerod, LP; Parry, AK; Saleem, PT, 1994) |
| "In fact, Reyes developed neuroleptic malignant syndrome (NMS) as a direct result of the antipsychotic medications she was administered." | 1.29 | Neuroleptic malignant syndrome: liability in nursing practice. ( Blair, DT; Dauner, A, 1993) |
| "A fatal case of Neuroleptic Malignant Syndrome (NMS) affecting a middle-aged woman is presented." | 1.29 | A fatal case of neuroleptic malignant syndrome. ( Lannas, PA; Pachar, JV, 1993) |
| "Fever is generally considered to be an essential feature of neuroleptic malignant syndrome (NMS)." | 1.29 | Case study: neuroleptic malignant syndrome without pyrexia. ( Hynes, AF; Vickar, EL, 1996) |
| " We discuss a possible relation between serotonin syndrome and a highly dosed combination therapy with moclobemide." | 1.29 | [Depressive stupor--malignant neuroleptic syndrome--serotonin syndrome. A case contribution to a difficult differential diagnosis]. ( König, F; Löble, M; Wolfersdorf, M, 1996) |
| "This case comes into the so-called neuroleptic malignant syndrome which can rarely arise in patients treated with antipsycotic agents and which causes high mortality, particularly when there are rhabdomyolysis and acute renal failure." | 1.29 | [Rhabdomyolysis and acute renal failure caused by haloperidol-decanoate (neuroleptic malignant syndrome)]. ( Benati, F; Cesario, V; Lazzarin, M, 1996) |
| "A case of recurrent neuroleptic malignant syndrome (NMS) occurring in a 29-year-old man with mild mental handicap and a superadded psychotic disorder is described." | 1.28 | Recurrent neuroleptic malignant syndrome in a man with mild mental handicap. ( Bambrick, M; Wilson, D, 1992) |
| "A case is reported, in which fatal pulmonary embolism complicated the course of a neuroleptic malignant syndrome (NMS)." | 1.28 | [Malignant neuroleptic syndrome: complete anticoagulant treatment or not?]. ( van Agtmael, MA; van Harten, PN, 1992) |
| "Individuals with mental retardation are thought to be at greater risk, and some recommendations were offered to prevent recurrence." | 1.28 | Recurrence of neuroleptic malignant syndrome via an inadvertent rechallenge in a woman with mental retardation. ( Boyd, RD, 1992) |
| "This suggests that neuroleptic malignant syndrome is caused by a peripheral, not central, effect of haloperidol." | 1.28 | Fatal hyperthermia in a quadriplegic man. Possible evidence for a peripheral action of haloperidol in neuroleptic malignant syndrome. ( Downey, JA; Downey, RJ; Newhouse, E; Weissman, C, 1992) |
| "A case of neuroleptic malignant syndrome (NMS) is described in a congenitally brain-damaged deaf patient." | 1.28 | Neuroleptic malignant syndrome and preexisting brain damage. ( Lazarus, A, 1992) |
| "Development of neuroleptic malignant syndrome (NMS) following discontinuation of high-dose and high-potency neuroleptic agents is described." | 1.28 | Neuroleptic malignant syndrome during abrupt reduction of neuroleptic treatment. ( Hermesh, H; Munitz, H; Spivak, B; Tyano, S; Weizman, A; Wolovick, L, 1990) |
| "The management of the neuroleptic malignant syndrome and its complications is discussed." | 1.28 | Neuroleptic malignant syndrome with renal and respiratory complications--a case report. ( Liam, CK; Ong, SB, 1990) |
| "Pretreatment with bromocriptine conferred no protection against the syndrome." | 1.28 | Porcine stress syndrome: an animal model for the neuroleptic malignant syndrome? ( Keck, PE; McElroy, SL; Pope, HG; Seeler, DC, 1990) |
| "The natural course of untreated neuroleptic malignant syndrome (NMS) does not usually exceed 3 weeks." | 1.28 | [Protracted recurrent neuroleptic malignant syndrome]. ( Delerue, O; Destée, A, 1990) |
| "The neuroleptic malignant syndrome is a serious and potentially fatal complication of neuroleptic and other dopamine antagonist drugs that are commonly used in symptom control in advanced cancer." | 1.28 | The neuroleptic malignant syndrome. ( O'Neill, WM, 1990) |
| "Neuroleptic-induced catatonia (NIC) and milder neuroleptic malignant syndrome (NMS) share parkinsonian features, catatonic symptoms, mild fever, and have been described in patients receiving antipsychotic agents." | 1.28 | Neuroleptic-induced catatonia or a mild form of neuroleptic malignant syndrome? ( Christodoulou, GN; Kontaxakis, VP; Vaidakis, NM; Valergaki, HC, 1990) |
| "This article describes a patient with lethal catatonia: treatment by ECT alone was ineffective, whereas continued treatment with ECT in combination with dantrolene sodium led to improvement." | 1.28 | Treatment of lethal catatonia with electroconvulsive therapy and dantrolene sodium: a case report. ( Nolen, WA; Zwaan, WA, 1990) |
| "A case of neuroleptic malignant syndrome is described in a 37-year-old man with mental retardation, hypomania and a history of recent hepatitis B infection." | 1.28 | Neuroleptic malignant syndrome with hypomania and mental retardation. ( Corbett, JA; Ward, MR, 1989) |
| "Two typical recurrent episodes of neuroleptic malignant syndrome (NMS) in the same patient are described." | 1.27 | Recurrent neuroleptic malignant syndrome due to tiapride and haloperidol: the possible role of D-2 dopamine receptors. ( Hermesh, H; Huberman, M; Kott, E; Radvan, H, 1984) |
| "ARDS and disseminated intravascular coagulation may be important, atypical signs encountered early in NMS and complicating its recognition." | 1.27 | Neuroleptic malignant syndrome presenting as adult respiratory distress syndrome and disseminated intravascular coagulation. ( Baxter, JW; Johnson, MD; Newman, JH, 1988) |
| "A case of neuroleptic malignant syndrome (NMS) with an abrupt onset was terminated quickly with i." | 1.27 | Resolution of neuroleptic malignant syndrome with dantrolene sodium: case report. ( Jaffe, JH; Khan, A; Morrison, B; Nelson, WH, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 58 (26.24) | 18.7374 |
| 1990's | 93 (42.08) | 18.2507 |
| 2000's | 47 (21.27) | 29.6817 |
| 2010's | 18 (8.14) | 24.3611 |
| 2020's | 5 (2.26) | 2.80 |
| Authors | Studies |
|---|---|
| Marloth, PV | 1 |
| Ladefoged, MR | 1 |
| Boesen, MS | 1 |
| Matos, CRC | 1 |
| Beirão, EMDCSP | 1 |
| Neves, RS | 1 |
| Assunção, AJ | 1 |
| Marques, RM | 1 |
| Sato, I | 1 |
| Onishi, H | 2 |
| Kawanishi, C | 2 |
| Yamada, S | 1 |
| Ishida, M | 1 |
| Kawakami, K | 1 |
| Kajani, R | 1 |
| Apramian, A | 1 |
| Vega, A | 1 |
| Ubhayakar, N | 1 |
| Xu, P | 1 |
| Liu, A | 1 |
| Prakash, S | 1 |
| Lodha, D | 1 |
| Rawat, KS | 1 |
| Wystub, N | 1 |
| Heymel, S | 1 |
| Fritzenwanger, M | 1 |
| Schulze, PC | 1 |
| Pfeifer, R | 1 |
| Whyte, CJ | 1 |
| Rosini, JM | 1 |
| Hardman, MI | 1 |
| Sprung, J | 1 |
| Weingarten, TN | 1 |
| Harley, JA | 1 |
| Peebles, C | 1 |
| Porter, RJ | 1 |
| Dixit, D | 1 |
| Shrestha, P | 1 |
| Adelman, M | 1 |
| Zou, D | 1 |
| Shao, Y | 1 |
| Qin, Z | 1 |
| Zhang, J | 1 |
| Liu, N | 1 |
| Li, Z | 1 |
| Huang, P | 1 |
| Chen, Y | 1 |
| Oka, M | 1 |
| Komasawa, N | 1 |
| Nishihara, I | 1 |
| Fukuda, M | 1 |
| Minami, T | 1 |
| Kameda, K | 1 |
| Watarai, K | 1 |
| Takahashi, K | 1 |
| Shoko, T | 1 |
| Koinuma, M | 1 |
| Ikushima, G | 1 |
| Sirois, F | 1 |
| Bellamy, CJ | 1 |
| Kane-Gill, SL | 1 |
| Falcione, BA | 1 |
| Seybert, AL | 1 |
| Dan, A | 1 |
| Bharadwaj, R | 1 |
| Grover, S | 1 |
| Chitaia, NN | 1 |
| Danilov, DS | 1 |
| Tiuvina, NA | 1 |
| Rock, W | 1 |
| Elias, M | 1 |
| Lev, A | 1 |
| Saliba, WR | 1 |
| Askenazy, F | 1 |
| Dor, E | 1 |
| Benoit, M | 1 |
| Dupuis, G | 1 |
| Serret, S | 1 |
| Myquel, M | 1 |
| Seddiki, Y | 1 |
| Yanagawa, Y | 1 |
| Miyazaki, M | 1 |
| Zivković, M | 1 |
| Mihaljević-Peles, A | 1 |
| Sagud, M | 1 |
| Silić, A | 1 |
| Mihanović, M | 1 |
| Özdemir, B | 1 |
| Çelik, C | 1 |
| Çinar, A | 1 |
| Özşahin, A | 1 |
| Steele, D | 1 |
| Keltner, NL | 1 |
| McGuiness, TM | 1 |
| Sokoro, AA | 1 |
| Zivot, J | 1 |
| Ariano, RE | 1 |
| Ghaffari, N | 1 |
| Dossett, E | 1 |
| Lee, RH | 1 |
| Aghajanian, P | 1 |
| Wysokiński, A | 1 |
| Russell, T | 1 |
| Riazi, S | 1 |
| Kraeva, N | 1 |
| Steel, AC | 1 |
| Hawryluck, LA | 1 |
| Crosby, D | 1 |
| Peterson, J | 1 |
| Carroll, BT | 1 |
| Desai, ND | 1 |
| Mundra, VK | 1 |
| Gore, YS | 1 |
| Diwan, PJ | 1 |
| Jaydeokar, SS | 1 |
| Jain, V | 1 |
| Sutharsan, R | 1 |
| Agarwal, A | 1 |
| Moulick, ND | 1 |
| Manocha, SM | 1 |
| Ghaziuddin, N | 1 |
| Alkhouri, I | 1 |
| Champine, D | 1 |
| Quinlan, P | 1 |
| Fluent, T | 1 |
| Ghaziuddin, M | 1 |
| Bhan, S | 1 |
| Kulkarni, V | 1 |
| Mehta, Y | 1 |
| Sharma, KK | 1 |
| Trehan, N | 1 |
| Suri, ML | 1 |
| Spivak, M | 1 |
| Adams, B | 1 |
| Crockford, D | 1 |
| Hillis, RE | 1 |
| Lee, DA | 1 |
| Kadyan, V | 1 |
| Colachis, SC | 1 |
| Depalma, MJ | 1 |
| Sanderson, JD | 1 |
| Mysiw, WJ | 1 |
| Kopf, A | 1 |
| Köster, J | 1 |
| Schulz, A | 1 |
| Krömker, H | 1 |
| Becker, T | 1 |
| Brieger, P | 1 |
| Reinelt, Y | 1 |
| Rosebush, PI | 1 |
| Garside, S | 1 |
| Mazurek, MF | 1 |
| Margetić, B | 1 |
| Aukst-Margetić, B | 1 |
| Morita, T | 1 |
| Shishido, H | 1 |
| Tei, Y | 1 |
| Inoue, S | 1 |
| Nagayama, K | 1 |
| Taskapan, C | 1 |
| Sahin, I | 1 |
| Taskapan, H | 1 |
| Kaya, B | 1 |
| Kosar, F | 1 |
| Mendhekar, DN | 1 |
| Jiloha, RC | 1 |
| Charra, B | 1 |
| Nejmi, H | 1 |
| Hachimi, A | 1 |
| Benslama, A | 1 |
| Motaouakkil, S | 1 |
| Tadke, RR | 1 |
| Suryavanshi, P | 1 |
| Strawn, JR | 1 |
| Keck, PE | 2 |
| Memis, D | 1 |
| Bayrak, F | 1 |
| Tokatlioglu, D | 1 |
| Gorman, JM | 1 |
| Kemp, WL | 1 |
| Fitzgerald, J | 1 |
| White, CL | 1 |
| Casademont, J | 1 |
| Garrabou, G | 1 |
| Miró, O | 1 |
| López, S | 1 |
| Pons, A | 1 |
| Bernardo, M | 1 |
| Cardellach, F | 1 |
| Diedler, J | 1 |
| Mellado, P | 1 |
| Veltkamp, R | 1 |
| Cesario, V | 2 |
| Bismuth, C | 1 |
| de Rohan-Chabot, P | 1 |
| Goulon, M | 1 |
| Raphael, JC | 1 |
| Hermesh, H | 6 |
| Huberman, M | 1 |
| Radvan, H | 1 |
| Kott, E | 1 |
| Konikoff, F | 1 |
| Kuritzky, A | 1 |
| Jerushalmi, Y | 1 |
| Theodor, E | 1 |
| Gangadhar, BN | 1 |
| Desai, NG | 1 |
| Channabasavanna, SM | 1 |
| Gómez, EA | 1 |
| Burke, C | 1 |
| Fulda, GJ | 1 |
| Castellano, J | 1 |
| Daras, M | 1 |
| Kakkouras, L | 1 |
| Tuchman, AJ | 1 |
| Koppel, BS | 1 |
| Raitasuo, V | 1 |
| Vataja, R | 1 |
| Elomaa, E | 1 |
| Marsh, SJ | 1 |
| Dolson, GM | 1 |
| Calore, EE | 1 |
| Cavaliere, MJ | 1 |
| Perez, NM | 1 |
| Russo, DH | 1 |
| Wakamatsu, A | 1 |
| Razzouk, D | 1 |
| Harada, H | 1 |
| Igarashi, M | 1 |
| Sugae, S | 1 |
| Okamoto, K | 1 |
| Tsuji, M | 1 |
| Nakajima, T | 1 |
| Raja, M | 1 |
| Altavista, MC | 1 |
| Cavallari, S | 1 |
| Lubich, L | 1 |
| Nisijima, K | 2 |
| Matoba, M | 1 |
| Ishiguro, T | 2 |
| Parry, AK | 1 |
| Ormerod, LP | 1 |
| Hamlin, GW | 1 |
| Saleem, PT | 1 |
| Kimura, T | 1 |
| Yoshida, H | 1 |
| Teo, SK | 1 |
| Lam, KN | 1 |
| Chew, WL | 1 |
| Blair, DT | 1 |
| Dauner, A | 1 |
| Greedharry, D | 1 |
| Bowen, R | 1 |
| Verwiel, JM | 1 |
| Verwey, B | 1 |
| Heinis, C | 1 |
| Thies, JE | 1 |
| Bosch, FH | 1 |
| Sing, RF | 2 |
| Branas, CC | 1 |
| Marino, PL | 1 |
| Lannas, PA | 1 |
| Pachar, JV | 1 |
| Garcia, FM | 1 |
| Duarte, J | 1 |
| Perez, A | 1 |
| Mataix, AL | 1 |
| Coria, F | 1 |
| Clavería, LE | 1 |
| Landry, P | 1 |
| Latour, J | 1 |
| Hirst, R | 1 |
| Galloway, GQ | 1 |
| Borzotta, AP | 1 |
| Dammers, S | 1 |
| Zeit, T | 1 |
| Leonhardt, M | 1 |
| Schär, V | 1 |
| Agelink, MW | 1 |
| Röther, J | 1 |
| Jakob, J | 1 |
| Bender, HJ | 1 |
| Hewer, W | 1 |
| Thomason, MH | 1 |
| Korzets, Z | 1 |
| Zelter, E | 1 |
| Bernheim, J | 1 |
| Hynes, AF | 1 |
| Vickar, EL | 1 |
| Real Rodríguez, B | 1 |
| Ruibal, JL | 1 |
| Grande Rodríguez, S | 1 |
| Sueiro Pita, B | 1 |
| Takahashi, A | 1 |
| Todoroki, J | 1 |
| Murasaki, M | 1 |
| Jauss, M | 1 |
| Krack, P | 1 |
| Franz, M | 1 |
| Klett, R | 1 |
| Bauer, R | 1 |
| Gallhofer, B | 1 |
| Dorndorf, W | 1 |
| Bryois, C | 1 |
| Bondolfi, G | 1 |
| König, F | 1 |
| Löble, M | 1 |
| Wolfersdorf, M | 1 |
| Martius, P | 1 |
| Hüther, R | 1 |
| Zilker, T | 1 |
| Tanii, H | 1 |
| Taniguchi, N | 1 |
| Niigawa, H | 1 |
| Hosono, T | 1 |
| Ikura, Y | 1 |
| Sakamoto, S | 1 |
| Kudo, T | 1 |
| Nishimura, T | 1 |
| Takeda, M | 1 |
| Lazzarin, M | 1 |
| Benati, F | 1 |
| Gaitini, L | 1 |
| Fradis, M | 1 |
| Vaida, S | 1 |
| Krimerman, S | 1 |
| Beny, A | 1 |
| Manor, I | 1 |
| Munitz, H | 5 |
| Weizman, A | 3 |
| Podschus, J | 1 |
| Kirsch, J | 1 |
| van Heys, R | 1 |
| Winzer, B | 1 |
| McKinney, P | 1 |
| Kellner, C | 1 |
| Garrido, SM | 1 |
| Chauncey, TR | 1 |
| Thomas, P | 1 |
| Maron, M | 1 |
| Rascle, C | 1 |
| Cottencin, O | 1 |
| Vaiva, G | 1 |
| Goudemand, M | 1 |
| Seki, Y | 1 |
| Takahashi, H | 2 |
| Aizawa, Y | 1 |
| Black, KJ | 1 |
| Racette, B | 1 |
| Perlmutter, JS | 1 |
| Suzuki, I | 1 |
| Honma, H | 1 |
| Watanabe, N | 1 |
| Matsubara, S | 1 |
| Koyama, T | 1 |
| Still, J | 1 |
| Friedman, B | 1 |
| Law, E | 1 |
| Deppe, S | 1 |
| Epperly, N | 1 |
| Orlet, H | 1 |
| Tanaka, K | 1 |
| Akechi, T | 1 |
| Yamazaki, M | 1 |
| Hayashi, R | 1 |
| Nishiwaki, Y | 1 |
| Uchitomi, Y | 1 |
| Hanel, RA | 1 |
| Sandmann, MC | 1 |
| Kranich, M | 1 |
| De Bittencourt, PR | 1 |
| Trasmonte, J | 1 |
| Dayner, J | 1 |
| Barron, TF | 1 |
| Wilkinson, R | 1 |
| Meythaler, JM | 1 |
| Guin-Renfroe, S | 1 |
| Sugimoto, T | 1 |
| Tsunoda, S | 1 |
| Shindou, K | 1 |
| Shiozawa, Z | 1 |
| Ghani, SO | 1 |
| Ahmed, W | 1 |
| Marco, LA | 1 |
| Yoshikawa, H | 1 |
| Watanabe, T | 1 |
| Abe, T | 1 |
| Oda, Y | 1 |
| Ozawa, K | 1 |
| Spencer, J | 1 |
| Cavagna, D | 1 |
| Zorzato, F | 1 |
| Babini, E | 1 |
| Prestipino, G | 1 |
| Treves, S | 1 |
| Weitzel, C | 1 |
| Yoshida, K | 1 |
| Sato, K | 1 |
| Higuchi, H | 2 |
| Shimizu, T | 1 |
| Dursun, A | 1 |
| Yilma, Y | 1 |
| Ozsari, M | 1 |
| Kandemir, N | 1 |
| Coşkun, T | 1 |
| Sule, A | 1 |
| Gohar, S | 1 |
| Mittal, G | 1 |
| Balakrishnan, C | 1 |
| Mangat, G | 1 |
| Joshi, VR | 1 |
| Mujica, R | 1 |
| Weiden, P | 1 |
| Ty, EB | 1 |
| Rothner, AD | 1 |
| Reeves, RR | 1 |
| Mack, JE | 1 |
| Torres, RA | 1 |
| Garcia, G | 1 |
| Ghani, S | 1 |
| Poveda, RA | 1 |
| Dansky, BL | 1 |
| Espino García, A | 1 |
| Madrid Valls, M | 1 |
| Mur Garcés, R | 1 |
| Nadal Braqué, N | 1 |
| Gerbershagen, MU | 1 |
| Ito, WD | 1 |
| Wappler, F | 1 |
| Fiege, M | 1 |
| Schulte am Esch, J | 1 |
| Korn-Lubetzki, I | 1 |
| Gottlieb, S | 1 |
| Wang, HC | 1 |
| Hsieh, Y | 1 |
| Russell, CS | 1 |
| Lang, C | 1 |
| McCambridge, M | 1 |
| Calhoun, B | 1 |
| Adachi, Y | 1 |
| Wada, H | 1 |
| Watanabe, K | 1 |
| Satoh, T | 1 |
| Hatch, CD | 1 |
| Lund, BC | 1 |
| Perry, PJ | 1 |
| Ueki, A | 1 |
| Iwado, H | 1 |
| Shinjo, H | 1 |
| Morita, Y | 1 |
| Neu, P | 1 |
| Seyfert, S | 1 |
| Brockmöller, J | 1 |
| Dettling, M | 1 |
| Marx, P | 1 |
| Fekadu, A | 1 |
| Wakwoya, A | 1 |
| Onose, M | 1 |
| Yamada, T | 1 |
| Itoh, M | 1 |
| Kosaka, K | 1 |
| Taguchi, J | 1 |
| Fujisawa, S | 1 |
| Kanamori, H | 1 |
| McHugh, TP | 1 |
| Aizenberg, D | 1 |
| Lapidot, M | 1 |
| Mayor, C | 1 |
| Bambrick, M | 1 |
| Wilson, D | 1 |
| Rao, KA | 1 |
| Adlakha, A | 1 |
| Meloy, T | 1 |
| Steadman, P | 1 |
| Akpaffiong, MJ | 1 |
| van Agtmael, MA | 1 |
| van Harten, PN | 1 |
| Woodbury, MM | 1 |
| Woodbury, MA | 1 |
| Jahan, MS | 1 |
| Farooque, AI | 1 |
| Wahid, Z | 1 |
| Ottervanger, JP | 1 |
| Gerbrandy-Colijn, A | 1 |
| Stricker, BH | 1 |
| Lee, K | 1 |
| Romero, JA | 1 |
| Tsuang, M | 1 |
| Balzan, M | 1 |
| Cacciottolo, JM | 1 |
| Mateo, D | 1 |
| Muñoz-Blanco, JL | 1 |
| Giménez-Roldán, S | 1 |
| Velamoor, VR | 2 |
| Boyd, RD | 1 |
| Aisen, PS | 1 |
| Lawlor, BA | 1 |
| Downey, RJ | 1 |
| Downey, JA | 1 |
| Newhouse, E | 1 |
| Weissman, C | 1 |
| Lazarus, A | 2 |
| Ghodhbane, T | 1 |
| Roffe, C | 1 |
| Patel, V | 1 |
| Abbott, RJ | 1 |
| Czapla, K | 1 |
| Watts, D | 1 |
| Otani, K | 2 |
| Kaneko, S | 2 |
| Fukushima, Y | 2 |
| Chiba, K | 1 |
| Ishizaki, T | 1 |
| Minamisawa, S | 1 |
| Tezuka, T | 1 |
| Enomoto, K | 1 |
| Nozaki, Y | 1 |
| Funatomi, H | 1 |
| Hatta, Y | 1 |
| Patkar, AA | 1 |
| Shah, LP | 1 |
| Mihara, K | 1 |
| Okada, M | 1 |
| Gertz, HJ | 1 |
| Schmidt, LG | 1 |
| Chandler, JD | 1 |
| Ziehm, SR | 1 |
| Spivak, B | 1 |
| Wolovick, L | 1 |
| Tyano, S | 1 |
| Liam, CK | 1 |
| Ong, SB | 1 |
| Usandizaga, I | 1 |
| Pérez de Mendiola, MM | 1 |
| Buades, J | 1 |
| Martínez, J | 1 |
| Seeler, DC | 1 |
| Pope, HG | 1 |
| McElroy, SL | 1 |
| Kemperman, CJ | 1 |
| van den Hoofdakker, RH | 1 |
| Paul, GE | 1 |
| Landers, DF | 1 |
| Newman, T | 1 |
| Bennett, DA | 1 |
| Delerue, O | 1 |
| Destée, A | 1 |
| O'Neill, WM | 1 |
| Haisma, HJ | 1 |
| Constantinou, E | 1 |
| Chinyanga, HM | 1 |
| Kontaxakis, VP | 1 |
| Vaidakis, NM | 1 |
| Christodoulou, GN | 1 |
| Valergaki, HC | 1 |
| Levitt, AJ | 1 |
| Midha, R | 1 |
| Craven, JL | 1 |
| Nolen, WA | 1 |
| Zwaan, WA | 1 |
| Lee, TH | 1 |
| Tang, LM | 1 |
| Diedrich, U | 1 |
| Müller, P | 1 |
| Kellner, CH | 1 |
| Melvin, JA | 1 |
| Shalev, A | 3 |
| Heird, SB | 1 |
| Rhoads, JE | 1 |
| Agarwal, NN | 1 |
| Ryken, TC | 1 |
| Merrell, AN | 1 |
| Green, BH | 1 |
| Price, DK | 1 |
| Turnbull, GJ | 1 |
| Gregory, RP | 1 |
| Stevens, DG | 1 |
| Lee, S | 1 |
| Merriam, A | 1 |
| Kim, TS | 1 |
| Liebling, M | 1 |
| Dickson, DW | 1 |
| Moore, GR | 1 |
| Quinn, DE | 1 |
| Goodman, MA | 1 |
| Sirota, P | 1 |
| Eviatar, J | 1 |
| Burch, EA | 1 |
| Montoya, J | 1 |
| Ward, MR | 1 |
| Corbett, JA | 1 |
| Lavie, CJ | 1 |
| Ventura, HO | 1 |
| Walker, G | 1 |
| O'Brien, PJ | 1 |
| Legras, A | 1 |
| Hurel, D | 1 |
| Dabrowski, G | 1 |
| Grenet, D | 1 |
| Graveleau, P | 1 |
| Loirat, P | 1 |
| Ansseau, M | 1 |
| Reynolds, CF | 1 |
| Kupfer, DJ | 1 |
| Poncelet, PF | 1 |
| Franck, G | 1 |
| Dresse, AE | 1 |
| Reznik, M | 1 |
| Finucane, P | 1 |
| Price, C | 1 |
| Ghose, K | 1 |
| Maniam, T | 1 |
| Jamaluddin, J | 1 |
| Kyaw, O | 1 |
| O'Brien, P | 1 |
| Bhatia, MS | 1 |
| Singhal, PK | 1 |
| Bohra, N | 1 |
| Kaur, N | 1 |
| Osser, DN | 1 |
| Stewart, TD | 1 |
| McNally, RJ | 1 |
| Calamari, JE | 1 |
| Hosford, I | 1 |
| Fernando, N | 1 |
| Miller, M | 1 |
| Addonizio, G | 1 |
| Johnson, MD | 1 |
| Newman, JH | 1 |
| Baxter, JW | 1 |
| Ursano, RJ | 1 |
| Schultz, V | 1 |
| Hemmingsen, R | 1 |
| Merriam, AE | 1 |
| Gotouda, H | 1 |
| Nagao, M | 1 |
| Mizukami, K | 1 |
| Takatori, T | 1 |
| Lowe, MR | 1 |
| Batchelor, DH | 1 |
| Mahmoodian, S | 1 |
| Harris, M | 1 |
| Nora, L | 1 |
| Tanner, CM | 1 |
| Rampertaap, MP | 1 |
| Beaubrun, MH | 1 |
| Patrick, AL | 1 |
| Perera, HV | 1 |
| Woo, J | 1 |
| Teoh, R | 1 |
| Vallance-Owen, J | 1 |
| Di Stasi, V | 1 |
| Serby, M | 1 |
| Yamawaki, S | 1 |
| Yanagawa, K | 1 |
| Morio, M | 1 |
| Mori, K | 1 |
| Liskow, BI | 1 |
| Chen, CC | 1 |
| Chen, SS | 1 |
| Wen, JK | 1 |
| Khan, A | 1 |
| Jaffe, JH | 1 |
| Nelson, WH | 1 |
| Morrison, B | 1 |
| Schibuk, M | 1 |
| Schachter, D | 1 |
| Vincent, FM | 1 |
| Zimmerman, JE | 1 |
| Van Haren, J | 1 |
| Verhoeven, WM | 2 |
| Elderson, A | 2 |
| Misiaszek, JJ | 1 |
| Potter, RL | 1 |
| Giordani, L | 1 |
| Amore, M | 1 |
| Montanari, A | 1 |
| Berlinzani, L | 1 |
| Gentili, C | 1 |
| Martin, ML | 1 |
| Lucid, EJ | 1 |
| Walker, RW | 1 |
| Westenberg, HG | 1 |
| Capellà Hereu, D | 1 |
| Cabeza Gutés, D | 1 |
| Laporte Roselló, JR | 1 |
| Pelonero, AL | 1 |
| Levenson, JL | 1 |
| Silverman, JJ | 1 |
24 reviews available for haloperidol and Neuroleptic Malignant Syndrome
| Article | Year |
|---|---|
Neuroleptic malignant syndrome in patients with cancer: a systematic review.
Topics: Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Dantrolene; Dopamine D2 Receptor Antagonists; | 2020 |
Acute phenibut withdrawal: A comprehensive literature review and illustrative case report.
Topics: Akathisia, Drug-Induced; Baclofen; Cyproheptadine; Dexmedetomidine; Diphenhydramine; GABA-A Receptor | 2019 |
Neuroleptic malignant syndrome in traumatic brain injury patients treated with haloperidol.
Topics: Adolescent; Adult; Antipsychotic Agents; Brain Injuries; Cerebral Hemorrhage, Traumatic; Combined Mo | 2009 |
[Life threatening neuroleptic malignant syndrome due to olanzapine].
Topics: Antipsychotic Agents; Benzodiazepines; Critical Care; Electroconvulsive Therapy; Female; Haloperidol | 2003 |
Neuroleptic malignant syndrome in a trauma patient.
Topics: Adult; Antipsychotic Agents; Dantrolene; Droperidol; Haloperidol; Humans; Male; Multiple Trauma; Mus | 1995 |
[Clinical study of neuroleptic malignant syndrome in demented patients--examination of our case and reported cases].
Topics: Aged; Aged, 80 and over; Dementia; Dementia, Vascular; Female; Haloperidol; Humans; Male; Middle Age | 1994 |
Neuroleptic malignant syndrome in the intensive care unit.
Topics: Adult; Haloperidol; Humans; Intensive Care Units; Male; Neuroleptic Malignant Syndrome | 1993 |
[The neuroleptic malignant syndrome].
Topics: Adult; Amantadine; Antiparkinson Agents; Antipsychotic Agents; Benperidol; Combined Modality Therapy | 1995 |
[The neuroleptic malignant syndrome in an adolescent. Its treatment with dantrolene, bromocryptin and diazepam].
Topics: Adolescent; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Antiparkinson Agents; Antipsychot | 1996 |
[Neuroleptic malignant syndrome, syndrome malin].
Topics: Calcium; Dopamine; Haloperidol; Humans; Neuroleptic Malignant Syndrome; Neurotransmitter Agents; Psy | 1996 |
[Neuroleptic malignant syndrome].
Topics: Adolescent; Adult; Antipsychotic Agents; Diagnosis, Differential; Dibenzothiazepines; Female; Halope | 1996 |
Neuroleptic malignant syndrome and severe thrombocytopenia: case report and literature review.
Topics: Adult; Antipsychotic Agents; Drug Therapy, Combination; Haloperidol; Humans; Male; Neuroleptic Malig | 2000 |
Haloperidol-induced rhabdomyolysis without neuroleptic malignant syndrome in a handicapped child.
Topics: Anti-Dyskinesia Agents; Child; Disabled Persons; Haloperidol; Humans; Male; Movement Disorders; Neur | 2000 |
Neuroleptic malignant syndrome in children and adolescents.
Topics: Adolescent; Adult; Antipsychotic Agents; Child; Depressive Disorder, Major; Female; Haloperidol; Hum | 2001 |
Neuroleptic-induced catatonia as a stage in the progression toward neuroleptic malignant syndrome.
Topics: Adolescent; Catatonia; Drug Therapy, Combination; Haloperidol; Humans; Lorazepam; Male; Neuroleptic | 1992 |
Neuroleptic malignant syndrome.
Topics: Aged; Antidepressive Agents; Haloperidol; Humans; Lithium; Male; Middle Aged; Neuroleptic Malignant | 1992 |
Intravenous haloperidol for tranquilization in critical care patients: a review and critique.
Topics: Aged; Basal Ganglia Diseases; Critical Illness; Death, Sudden; Female; Haloperidol; Humans; Infusion | 1991 |
Neuroleptic malignant syndrome.
Topics: Adult; Female; Haloperidol; Humans; Neuroleptic Malignant Syndrome | 1990 |
Mortality from neuroleptic malignant syndrome.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Dantrolene; Dopamine Agents; Female; Haloperidol; | 1989 |
Cerebellar degeneration in neuroleptic malignant syndrome: neuropathologic findings and review of the literature concerning heat-related nervous system injury.
Topics: Adult; Cerebellar Diseases; Cerebellum; Chronic Disease; Dose-Response Relationship, Drug; Fever; Ha | 1989 |
The neuroleptic malignant syndrome: agent and host interaction.
Topics: Adolescent; Adult; Aftercare; Aged; Akathisia, Drug-Induced; Amantadine; Antiparkinson Agents; Antip | 1986 |
Neuroleptic malignant syndrome: case report and review.
Topics: Adult; Haloperidol; Humans; Male; Neuroleptic Malignant Syndrome | 1988 |
Neuroleptic malignant syndrome in elderly patients.
Topics: Aged; Haloperidol; Humans; Neuroleptic Malignant Syndrome | 1987 |
Neuroleptic malignant syndrome.
Topics: Adolescent; Adult; Benztropine; Bromocriptine; Catatonia; Child; Child, Preschool; Diagnosis, Differ | 1986 |
2 trials available for haloperidol and Neuroleptic Malignant Syndrome
| Article | Year |
|---|---|
Neuroleptic treatment effect on mitochondrial electron transport chain: peripheral blood mononuclear cells analysis in psychotic patients.
Topics: Adult; Antipsychotic Agents; Clozapine; Cross-Sectional Studies; Electron Transport; Electron Transp | 2007 |
Risk for definite neuroleptic malignant syndrome. A prospective study in 223 consecutive in-patients.
Topics: Administration, Oral; Antipsychotic Agents; Bipolar Disorder; Creatine Kinase; Female; Follow-Up Stu | 1992 |
195 other studies available for haloperidol and Neuroleptic Malignant Syndrome
| Article | Year |
|---|---|
[Neuroleptic malignant syndrome caused by olanzapine, risperidone and haloperidol].
Topics: Adult; Antipsychotic Agents; Haloperidol; Humans; Male; Neuroleptic Malignant Syndrome; Olanzapine; | 2022 |
When the fever will not stop, stop the pills! A case report.
Topics: Adult; Antipsychotic Agents; Female; Haloperidol; Humans; Neuroleptic Malignant Syndrome; Quetiapine | 2023 |
Neuroleptic malignant syndrome in a COVID-19 patient.
Topics: Acute Kidney Injury; Antipsychotic Agents; Betacoronavirus; Bromocriptine; C-Reactive Protein; Coron | 2020 |
Coexistence of serotonin syndrome and neuroleptic malignant syndrome: does it exist?
Topics: Adult; Antipsychotic Agents; Haloperidol; Humans; Male; Neuroleptic Malignant Syndrome; Risperidone; | 2021 |
[Prolonged neuroleptic malignant syndrome after Haloperidol injection].
Topics: Antipsychotic Agents; Dantrolene; Haloperidol; Humans; Male; Middle Aged; Neuroleptic Malignant Synd | 2018 |
Dantrolene for Treatment of Suspected Neuroleptic Malignant Syndrome.
Topics: Analgesics, Opioid; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Dantrolene; Diagnosis, D | 2018 |
Electroconvulsive therapy for catatonia secondary to neuroleptic malignant syndrome in a patient with multiple sclerosis.
Topics: Adult; Antipsychotic Agents; Catatonia; Electroconvulsive Therapy; Female; Hallucinations; Haloperid | 2019 |
Neuroleptic malignant syndrome associated with haloperidol use in critical care setting: should haloperidol still be considered the drug of choice for the management of delirium in the critical care setting?
Topics: Antipsychotic Agents; Critical Care; Delirium; Haloperidol; Humans; Male; Middle Aged; Neuroleptic M | 2013 |
Death due to fulminant neuroleptic malignant syndrome induced by low doses of haloperidol: a rare case.
Topics: Adult; Antipsychotic Agents; Creatinine; Dose-Response Relationship, Drug; Haloperidol; Humans; Leuk | 2014 |
[A Case of Neuroleptic Malignant Syndrome Associated with Undiagnosed Dementia with Lewy Bodies].
Topics: Aged; Female; Haloperidol; Humans; Lewy Body Disease; Neuroleptic Malignant Syndrome; Treatment Outc | 2015 |
Pharmaceutical Approach for the Diagnosis and Treatment of Malignant Syndrome: A Case Study.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Bromocriptine; Dantrolene; Drug Therapy, Combinat | 2016 |
Neuroleptic malignant syndrome and cardiac surgery. A case report.
Topics: Aged; Antipsychotic Agents; Cardiac Surgical Procedures; Diagnosis, Differential; Haloperidol; Human | 2008 |
Neuroleptic malignant syndrome with use of quetiapine in mental retardation.
Topics: Antipsychotic Agents; Dibenzothiazepines; Drug Therapy, Combination; Haloperidol; Humans; Intellectu | 2009 |
[Peculiarities of neuroleptic syndrome in women treated with typical and atypical neuroleptics].
Topics: Adult; Antipsychotic Agents; Clozapine; Dose-Response Relationship, Drug; Female; Follow-Up Studies; | 2009 |
Haloperidol-induced neuroleptic malignant syndrome complicated by hyperosmolar hyperglycemic state.
Topics: Adult; Antipsychotic Agents; Fatal Outcome; Haloperidol; Humans; Hyperglycemia; Male; Malignant Hype | 2009 |
[Catatonia in a 14 year-old girl: treatment with clorazepam and carbamazepine, a 10-year follow-up].
Topics: Acute Disease; Adolescent; Adult; Anticonvulsants; Antipsychotic Agents; Carbamazepine; Cataplexy; C | 2010 |
[Case with difficulty in differentiating between transient neuroleptic malignant syndrome and catatonia after neuroleptic analgesia].
Topics: Adolescent; Analgesia; Anesthesia, General; Catatonia; Diagnosis, Differential; Diazepam; Droperidol | 2010 |
The role of CYP2D6 and TaqI A polymorphisms in malignant neuroleptic syndrome: two case reports with three episodes.
Topics: Adult; Alleles; Antipsychotic Agents; Bipolar Disorder; Clozapine; Cytochrome P-450 CYP2D6; Dibenzot | 2010 |
Relief by electroconvulsive therapy for postsurgical delirium in malignant catatonia.
Topics: Antipsychotic Agents; Cardiac Surgical Procedures; Catatonia; Coronary Artery Bypass; Delirium; Elec | 2010 |
Are neuroleptic malignant syndrome and serotonin syndrome the same syndrome?
Topics: Antidepressive Agents, Tricyclic; Antipsychotic Agents; Dibenzothiazepines; Drug Therapy, Combinatio | 2011 |
Neuroleptic malignant syndrome versus serotonin syndrome: the search for a diagnostic tool.
Topics: Antipsychotic Agents; Catecholamines; Diagnosis, Differential; Dibenzothiazepines; Dopamine; Female; | 2011 |
Antipsychotics leading to neuroleptic malignant syndrome in pregnancy.
Topics: Adult; Antipsychotic Agents; Female; Haloperidol; Humans; Neuroleptic Malignant Syndrome; Pregnancy; | 2012 |
Intensive electroconvulsive therapy in drug resistant neuroleptic malignant syndrome - case report.
Topics: Adult; Antipsychotic Agents; Clozapine; Electroconvulsive Therapy; Haloperidol; Humans; Male; Neurol | 2012 |
Ecstacy-induced delayed rhabdomyolysis and neuroleptic malignant syndrome in a patient with a novel variant in the ryanodine receptor type 1 gene.
Topics: Anesthetics, Inhalation; Antipsychotic Agents; Body Temperature; Caffeine; Central Nervous System St | 2012 |
Atypical neuroleptic malignant syndrome in H1N1 pneumonia.
Topics: Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Creatine Kinase; Haloperidol; Humans; Influ | 2013 |
Neuroleptic malignant syndrome: an experience of four cases.
Topics: Adolescent; Adult; Antipsychotic Agents; Clozapine; Female; Haloperidol; Humans; Neuroleptic Maligna | 1998 |
ECT treatment of malignant catatonia/NMS in an adolescent: a useful lesson in delayed diagnosis and treatment.
Topics: Adolescent; Benzodiazepines; Brain; Catatonia; Diagnosis, Differential; Diagnostic Imaging; Electroc | 2002 |
Neuroleptic malignant syndrome: uncommon postoperative diagnostic dilemma.
Topics: Aged; Bromocriptine; Coronary Artery Bypass; Coronary Artery Disease; Dementia; Diagnosis, Different | 2002 |
Atypical neuroleptic malignant syndrome with clozapine and subsequent haloperidol treatment.
Topics: Adult; Antipsychotic Agents; Clozapine; Haloperidol; Humans; Male; Neuroleptic Malignant Syndrome; S | 2003 |
Viral encephalitis complicated by neuroleptic malignant syndrome in a 7-year-old girl.
Topics: Anticonvulsants; Carbidopa; Child; Dopamine Agents; Drug Therapy, Combination; Encephalitis, Viral; | 2003 |
Early recognition of neuroleptic malignant syndrome during traumatic brain injury rehabilitation.
Topics: Adult; Anti-Dyskinesia Agents; Antipsychotic Agents; Brain Injuries; Haloperidol; Humans; Male; Neur | 2003 |
No recurrence of a neuroleptic malignant syndrome under quetiapine.
Topics: Anticonvulsants; Antipsychotic Agents; Diazepam; Dibenzothiazepines; Drug Therapy, Combination; Halo | 2003 |
Recognizing neuroleptic malignant syndrome.
Topics: Aged; Aged, 80 and over; Creatine Kinase; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Ha | 2004 |
Neuroleptic malignant syndrome and clozapine withdrawal at the same time?
Topics: Adult; Antipsychotic Agents; Clozapine; Haloperidol; Humans; Male; Neuroleptic Malignant Syndrome; P | 2005 |
Neuroleptic malignant syndrome after haloperidol and fentanyl infusion in a patient with cancer with severe mineral imbalance.
Topics: Aged; Analgesics, Opioid; Dopamine Antagonists; Drug Therapy, Combination; Esophageal Neoplasms; Fen | 2004 |
Possible malignant neuroleptic syndrome that associated with hypothyroidism.
Topics: Adrenal Insufficiency; Antipsychotic Agents; Body Temperature; Clozapine; Female; Haloperidol; Human | 2005 |
Neuroleptic malignant syndrome precipitated by haloperidol following clozapine discontinuation.
Topics: Adult; Anti-Anxiety Agents; Antiparkinson Agents; Antipsychotic Agents; Bromocriptine; Clozapine; Cr | 2005 |
[Neuroleptic malignant syndrome].
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Coma; Combined Modality Therapy; Cryotherapy; Drug The | 2006 |
Use of intravenous valproate in a patient with neuroleptic malignant syndrome.
Topics: Adult; Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Creatine Kinase; Diagnosis, Differen | 2006 |
Early bicarbonate loading and dantroline for ziprasidone/haloperidol-induced neuroleptic malignant syndrome.
Topics: Adolescent; Antipsychotic Agents; Autistic Disorder; Combined Modality Therapy; Dantrolene; Disrupti | 2006 |
Neuroleptic malignant syndrome: a case report.
Topics: Adult; Antipsychotic Agents; Female; Haloperidol; Humans; Neuroleptic Malignant Syndrome; Schizophre | 2006 |
Undiagnosed progressive supranuclear palsy in a patient with neuroleptic malignant syndrome due to use of neuroleptics: the utility of autopsy in deaths due to known drug reactions.
Topics: Adult; Antipsychotic Agents; Brain; Female; Forensic Pathology; Haloperidol; Humans; Neuroleptic Mal | 2007 |
Endovascular cooling in a patient with neuroleptic malignant syndrome.
Topics: Antipsychotic Agents; Catheters, Indwelling; Creatine Kinase; Drug Synergism; Female; Fever; Haloper | 2008 |
[Acute extrapyramidal syndrome and neuroleptical malignant syndrome. A case report].
Topics: Acute Disease; Adult; Antipsychotic Agents; Basal Ganglia Diseases; Haloperidol; Humans; Injections, | 2008 |
Dantrolene--a new therapeutic approach to the neuroleptic malignant syndrome.
Topics: Adolescent; Adult; Basal Ganglia Diseases; Dantrolene; Haloperidol; Heat Exhaustion; Humans; Hyperte | 1984 |
Recurrent neuroleptic malignant syndrome due to tiapride and haloperidol: the possible role of D-2 dopamine receptors.
Topics: Basal Ganglia; Basal Ganglia Diseases; Benzamides; Dose-Response Relationship, Drug; Female; Haloper | 1984 |
Neuroleptic malignant syndrome induced by a single injection of haloperidol.
Topics: Basal Ganglia Diseases; Dantrolene; Female; Haloperidol; Humans; Middle Aged; Neuroleptic Malignant | 1984 |
Amantadine in the neuroleptic malignant syndrome.
Topics: Adult; Amantadine; Basal Ganglia Diseases; Haloperidol; Humans; Male; Neuroleptic Malignant Syndrome | 1984 |
[Extrapyramidal reactions and neuroleptic malignant syndrome].
Topics: Adult; Amantadine; Basal Ganglia Diseases; Dantrolene; Haloperidol; Humans; Male; Neuroleptic Malign | 1984 |
Rhabdomyolysis and hyperthermia after cocaine abuse: a variant of the neuroleptic malignant syndrome?
Topics: Adult; Antipsychotic Agents; Brain; Cell Death; Cocaine; Diagnosis, Differential; Diazepam; Female; | 1995 |
Risperidone-induced neuroleptic malignant syndrome in young patient.
Topics: Adult; Antipsychotic Agents; Haloperidol; Humans; Isoxazoles; Male; Neuroleptic Malignant Syndrome; | 1994 |
Rhabdomyolysis and acute renal failure during high-dose haloperidol therapy.
Topics: Acute Kidney Injury; Adult; Antipsychotic Agents; Haloperidol; Humans; Male; Neuroleptic Malignant S | 1995 |
Hyperthermic reaction to haloperidol with rigidity, associated to central core disease.
Topics: Adult; Diagnosis, Differential; Female; Haloperidol; Humans; Malignant Hyperthermia; Muscles; Myopat | 1994 |
A schizophrenic patient who developed extreme hypothermia after an increase in the dose of haloperidol: a case report.
Topics: Antipsychotic Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Haloperidol; Huma | 1994 |
Neuroleptic malignant syndrome and catatonia. A report of three cases.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Catatonia; Depressive Disorder; Dibenzothiazepines; D | 1994 |
Single photon emission computed tomography with 123I-IMP in three cases of the neuroleptic malignant syndrome.
Topics: Adult; Amphetamines; Antipsychotic Agents; Basal Ganglia; Brain; Dantrolene; Dose-Response Relations | 1994 |
Recurrent sinus arrest in association with neuroleptic malignant syndrome.
Topics: Adult; Antipsychotic Agents; Cardiac Pacing, Artificial; Catatonia; Chlorpromazine; Clopenthixol; Dr | 1994 |
A fulminant case of neuroleptic malignant syndrome.
Topics: Adult; Drug Therapy, Combination; Fatal Outcome; Haloperidol; Humans; Male; Neuroleptic Malignant Sy | 1994 |
Neuroleptic malignant syndrome: liability in nursing practice.
Topics: Adult; Antipsychotic Agents; Brain Damage, Chronic; Dose-Response Relationship, Drug; Female; Halope | 1993 |
Lethal catatonia and neuroleptic malignant syndrome.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Catatonia; Diagnosis, Differential; Dose-Response Rel | 1993 |
[Successful electroconvulsive therapy in a pregnant woman with neuroleptic malignant syndrome].
Topics: Adult; Electroconvulsive Therapy; Female; Haloperidol; Humans; Infant, Newborn; Mental Disorders; Ne | 1994 |
A fatal case of neuroleptic malignant syndrome.
Topics: Adult; Chemical and Drug Induced Liver Injury, Chronic; Female; Haloperidol; Humans; Liver Cirrhosis | 1993 |
Low serum iron and neuroleptic malignant syndrome.
Topics: Aged; Female; Haloperidol; Humans; Iron; Iron Deficiencies; Neuroleptic Malignant Syndrome | 1993 |
Neuroleptic malignant syndrome in communicating hydrocephaly and microcephaly.
Topics: Aged; Confusion; Drug Administration Schedule; Female; Haloperidol; Humans; Hydrocephalus; Microceph | 1993 |
Neuroleptic malignant syndrome: case report in a multiple trauma patient.
Topics: Adult; Bromocriptine; Female; Haloperidol; Humans; Multiple Trauma; Neuroleptic Malignant Syndrome | 1993 |
[Polytrauma and malignant neuroleptic syndrome. Case presentation with diagnostic problems].
Topics: Adult; Antipsychotic Agents; Chlorprothixene; Diagnosis, Differential; Drug Therapy, Combination; Ha | 1995 |
Neuroleptic malignant syndrome in a trauma patient.
Topics: Antipsychotic Agents; Haloperidol; Humans; Infusions, Intravenous; Neuroleptic Malignant Syndrome | 1996 |
Acute renal failure in the setting of the neuroleptic malignant syndrome.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Antipsychotic Agents; Dopamine Antagonists; Female; Ha | 1996 |
Case study: neuroleptic malignant syndrome without pyrexia.
Topics: Antipsychotic Agents; Child; Dose-Response Relationship, Drug; Drug Administration Schedule; Fever; | 1996 |
Imaging of dopamine receptors with [123I]iodobenzamide single-photon emission-computed tomography in neuroleptic malignant syndrome.
Topics: Adult; Antipsychotic Agents; Basal Ganglia; Benperidol; Benzamides; Dopamine Antagonists; Frontal Lo | 1996 |
[Depressive stupor--malignant neuroleptic syndrome--serotonin syndrome. A case contribution to a difficult differential diagnosis].
Topics: Antidepressive Agents, Tricyclic; Antipsychotic Agents; Benzamides; Depressive Disorder; Diagnosis, | 1996 |
[A case of malignant neuroleptic syndrome. Case report].
Topics: Adult; Antipsychotic Agents; Critical Care; Diagnosis, Differential; Dose-Response Relationship, Dru | 1996 |
Development of an animal model for neuroleptic malignant syndrome: heat-exposed rabbits with haloperidol and atropine administration exhibit increased muscle activity, hyperthermia, and high serum creatine phosphokinase level.
Topics: Animals; Antipsychotic Agents; Atropine; Body Temperature Regulation; Cholinergic Antagonists; Creat | 1996 |
[Rhabdomyolysis and acute renal failure caused by haloperidol-decanoate (neuroleptic malignant syndrome)].
Topics: Acute Kidney Injury; Antipsychotic Agents; Haloperidol; Humans; Male; Middle Aged; Neuroleptic Malig | 1996 |
Plasmapheresis in neuroleptic malignant syndrome.
Topics: Adult; Antipsychotic Agents; Body Temperature; Creatine Kinase; Haloperidol; Humans; Male; Neurolept | 1997 |
Neuroleptic malignant syndrome with gangliosidosis type II.
Topics: Adult; Antipsychotic Agents; Female; Haloperidol; Humans; Male; Neuroleptic Malignant Syndrome; Psyc | 1997 |
[Acute delusional psychosis and neuroleptic malignant syndrome after emigration of a Russian German patient].
Topics: Adult; Antipsychotic Agents; Delusions; Drug Therapy, Combination; Emigration and Immigration; Ethni | 1997 |
Multiple ECT late in the course of neuroleptic malignant syndrome.
Topics: Adult; Antipsychotic Agents; Electroconvulsive Therapy; Female; Haloperidol; Humans; Neuroleptic Mal | 1997 |
Neuroleptic malignant syndrome following autologous peripheral blood stem cell transplantation.
Topics: Antipsychotic Agents; Breast Neoplasms; Droperidol; Female; Haloperidol; Hematopoietic Stem Cell Tra | 1998 |
Carbamazepine in the treatment of neuroleptic malignant syndrome.
Topics: Adult; Anticonvulsants; Antipsychotic Agents; Carbamazepine; Depressive Disorder; Female; Haloperido | 1998 |
[Hemostatic evaluation of a patient with haloperidol-induced neuroleptic malignant syndrome associated with disseminated intravascular coagulation].
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Antipsychotic Agents; Blood Coagulation; Blood Coagula | 1998 |
Preventing contractures [correction of contractions] in neuroleptic malignant syndrome and dystonia.
Topics: Anti-Dyskinesia Agents; Botulinum Toxins; Combined Modality Therapy; Contracture; Dystonia; Female; | 1998 |
[A study of neuroleptic malignant syndrome in the presenium and senium].
Topics: Aged; Alzheimer Disease; Antipsychotic Agents; Dementia, Vascular; Female; Haloperidol; Humans; Male | 1998 |
Neuroleptic malignant syndrome in a burn patient.
Topics: Accidents, Occupational; Adult; Antipsychotic Agents; Bromocriptine; Burns; Dantrolene; Debridement; | 1998 |
Neuroleptic malignant syndrome during haloperidol treatment in a cancer patient. A case report.
Topics: Antipsychotic Agents; Carcinoma, Squamous Cell; Diagnosis, Differential; Haloperidol; Humans; Male; | 1998 |
[Neuroleptic malignant syndrome: case report with recurrence associated with the use of olanzapine].
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Chlorpromazine; Haloperidol; Humans; Male; Neuroleptic | 1998 |
Electroconvulsive therapy for the treatment of neuroleptic malignant syndrome with psychotic symptoms: a report of five cases.
Topics: Adult; Antipsychotic Agents; Depressive Disorder; Drug Therapy, Combination; Female; Haloperidol; Hu | 1999 |
Neuroleptic malignant syndrome in an adolescent head trauma patient.
Topics: Accidents, Traffic; Adolescent; Age Factors; Anti-Dyskinesia Agents; Bromocriptine; Craniocerebral T | 1999 |
Neuroleptic malignant syndrome induced by haloperidol following traumatic brain injury.
Topics: Adolescent; Amantadine; Brain Injuries; Dopamine Agents; Dopamine Antagonists; Fever; Haloperidol; H | 1999 |
[A case of neuroleptic malignant syndrome associated with reversible leukoencephalopathy].
Topics: Adrenal Cortex Hormones; Antipsychotic Agents; Female; Glycerol; Haloperidol; Humans; Leukoencephalo | 1999 |
Cannabis and psychosis.
Topics: Adolescent; Antipsychotic Agents; Haloperidol; Humans; Male; Neuroleptic Malignant Syndrome; Recurre | 2000 |
Methyl p-hydroxybenzoate (E-218) a preservative for drugs and food is an activator of the ryanodine receptor Ca(2+) release channel.
Topics: Animals; Antipsychotic Agents; Calcium; Dose-Response Relationship, Drug; Food Preservatives; Halope | 2000 |
Could you spot this psych emergency?
Topics: Adult; Antipsychotic Agents; Diagnosis, Differential; Emergencies; Haloperidol; Humans; Male; Neurol | 2000 |
Biperiden hydrochlorate ameliorates dystonia of rats produced by microinjection of sigma ligands into the red nucleus.
Topics: Animals; Anti-Dyskinesia Agents; Anticonvulsants; Biperiden; Disease Models, Animal; Guanidines; Hal | 2000 |
Neuroleptic malignant syndrome in a patient with citrullinaemia.
Topics: Antipsychotic Agents; Brain; Child; Citrullinemia; Fatal Outcome; Female; Haloperidol; Humans; Neuro | 2000 |
Neuroleptic malignant syndrome occurring in a suspected case of systemic lupus erythematosus.
Topics: Adult; Anti-Dyskinesia Agents; Fatal Outcome; Female; Haloperidol; Humans; Lupus Erythematosus, Syst | 2000 |
Neuroleptic malignant syndrome after addition of haloperidol to atypical antipsychotic.
Topics: Acute Disease; Adult; Antipsychotic Agents; Benzodiazepines; Drug Therapy, Combination; Emergency Se | 2001 |
Neuroleptic malignant syndrome during a change from haloperidol to risperidone.
Topics: Antipsychotic Agents; Haloperidol; Humans; Male; Middle Aged; Neuroleptic Malignant Syndrome; Risper | 2001 |
Neuroleptic malignant syndrome with antidepressant/antipsychotic drug combination.
Topics: Aged; Antidepressive Agents; Antipsychotic Agents; Clozapine; Drug Combinations; Haloperidol; Humans | 2001 |
[Malignant neuroleptic syndrome linked to haloperidol].
Topics: Aged; Aged, 80 and over; Dopamine Antagonists; Female; Haloperidol; Humans; Neuroleptic Malignant Sy | 2001 |
[Malignant neuroleptic syndrome after haloperidol administration].
Topics: Aged; Antipsychotic Agents; Catecholamines; Critical Care; Dantrolene; Depressive Disorder; Haloperi | 2001 |
Neuroleptic malignant syndrome with hypotonia: a diagnostic challenge.
Topics: Adult; Anti-Dyskinesia Agents; Haloperidol; Humans; Male; Muscle Hypotonia; Neuroleptic Malignant Sy | 2001 |
Treatment of neuroleptic malignant syndrome with subcutaneous apomorphine monotherapy.
Topics: Adult; Apomorphine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Co | 2001 |
Neuroleptic malignant syndrome in pregnancy.
Topics: Antipsychotic Agents; Female; Haloperidol; Humans; Neuroleptic Malignant Syndrome; Pneumonia, Viral; | 2001 |
[The effect of halothane anesthesia on dopamine release induced by apomorphine or haloperidol--an in vivo microdialysis study in rats striatum].
Topics: Anesthesia, Inhalation; Anesthetics, Inhalation; Animals; Antipsychotic Agents; Apomorphine; Corpus | 2001 |
Failed challenge with quetiapine after neuroleptic malignant syndrome with conventional antipsychotics.
Topics: Alzheimer Disease; Antipsychotic Agents; Chlorpromazine; Dibenzothiazepines; Haloperidol; Humans; Hy | 2001 |
[Malignant syndrome caused by a combination of bromperidol and donepezil hydrochloride in a patient with probable dementia with Lewy bodies].
Topics: Aged; Donepezil; Drug Therapy, Combination; Hallucinations; Haloperidol; Humans; Indans; Lewy Body D | 2001 |
Neuroleptic malignant syndrome in a patient with succinic semialdehyde dehydrogenase deficiency.
Topics: Adult; Aldehyde Oxidoreductases; Antipsychotic Agents; Cytochrome P-450 CYP2D6; Haloperidol; Humans; | 2002 |
Neuroleptic malignant syndrome: a case report.
Topics: Adolescent; Antipsychotic Agents; Chlorpromazine; Drug Therapy, Combination; Haloperidol; Humans; Ma | 1999 |
Neuroleptic malignant syndrome following BMT.
Topics: Bone Marrow Transplantation; Female; Haloperidol; Humans; Leukemia, Myeloid; Middle Aged; Neurolepti | 2002 |
Neuroleptic malignant syndrome.
Topics: Adult; Antipsychotic Agents; Diagnosis, Differential; Haloperidol; Humans; Male; Neuroleptic Maligna | 1992 |
Recurrent neuroleptic malignant syndrome in a man with mild mental handicap.
Topics: Adult; Antipsychotic Agents; Carbamazepine; Dose-Response Relationship, Drug; Drug Therapy, Combinat | 1992 |
Tremor, confusion, and autonomic dysfunction in Down syndrome.
Topics: Adult; Autonomic Nervous System Diseases; Confusion; Diagnosis, Differential; Down Syndrome; Haloper | 1992 |
Treatment of hypomania following neuroleptic malignant syndrome.
Topics: Adult; Arousal; Bipolar Disorder; Drug Therapy, Combination; Electroconvulsive Therapy; Haloperidol; | 1992 |
Risk factors for neuroleptic malignant syndrome.
Topics: Adult; Drug Therapy, Combination; Female; Haloperidol; Humans; Lithium; Neuroleptic Malignant Syndro | 1992 |
[Malignant neuroleptic syndrome: complete anticoagulant treatment or not?].
Topics: Adult; Anticoagulants; Biperiden; Depressive Disorder; Drug Therapy, Combination; Haloperidol; Human | 1992 |
[Fever caused by neuroleptics].
Topics: Adult; Delayed-Action Preparations; Female; Fever; Haloperidol; Humans; Male; Middle Aged; Neurolept | 1992 |
Late-onset atypical psychosis: a case involving neuroleptic drug toxicity and autoimmune serological abnormalities.
Topics: Autoimmune Diseases; Diagnosis, Differential; Haloperidol; Humans; Male; Middle Aged; Neurocognitive | 1992 |
Neuroleptic malignant syndrome presenting as hyperosmolar non-ketotic diabetic coma.
Topics: Body Temperature Regulation; Combined Modality Therapy; Depressive Disorder; Diagnosis, Differential | 1992 |
Neuroleptic malignant syndrome related to tetrabenazine introduction and haloperidol discontinuation in Huntington's disease.
Topics: Female; Haloperidol; Humans; Huntington Disease; Middle Aged; Neuroleptic Malignant Syndrome; Substa | 1992 |
NMS complicated by diazepam.
Topics: Aged; Coma; Diazepam; Haloperidol; Humans; Male; Neuroleptic Malignant Syndrome; Risk Factors; Schiz | 1992 |
Recurrence of neuroleptic malignant syndrome via an inadvertent rechallenge in a woman with mental retardation.
Topics: Adult; Depressive Disorder; Female; Haloperidol; Humans; Intellectual Disability; Neuroleptic Malign | 1992 |
Neuroleptic malignant syndrome induced by low-dose haloperidol.
Topics: Alzheimer Disease; Dose-Response Relationship, Drug; Female; Haloperidol; Humans; Injections, Intram | 1992 |
Fatal hyperthermia in a quadriplegic man. Possible evidence for a peripheral action of haloperidol in neuroleptic malignant syndrome.
Topics: Adult; Fever; Haloperidol; Humans; Male; Neuroleptic Malignant Syndrome; Quadriplegia; Spinal Cord I | 1992 |
Neuroleptic malignant syndrome and preexisting brain damage.
Topics: Adult; Brain Damage, Chronic; Drug Therapy, Combination; Haloperidol; Humans; Male; Neuroleptic Mali | 1992 |
[A feverish psychotic].
Topics: Adult; Chlorpromazine; Haloperidol; Humans; Male; Neuroleptic Malignant Syndrome; Schizophrenia | 1992 |
Peripheral neuropathy as a complication of neuroleptic malignant syndrome.
Topics: Adult; Axons; Bipolar Disorder; Electromyography; Female; Haloperidol; Humans; Neuroleptic Malignant | 1991 |
Neuroleptic malignant syndrome in a case of acute post-traumatic psychosis.
Topics: Antipsychotic Agents; Carbamazepine; Diagnosis, Differential; Haloperidol; Humans; Middle Aged; Neur | 1991 |
NMS and genetic drug oxidation.
Topics: Adult; Aged; Female; Haloperidol; Humans; Inactivation, Metabolic; Male; Middle Aged; Neuroleptic Ma | 1991 |
[A case of neuroleptic malignant syndrome developed in liver cirrhosis patient addicted to alcohol].
Topics: Adult; Ethanol; Haloperidol; Humans; Liver Cirrhosis, Alcoholic; Male; Neuroleptic Malignant Syndrom | 1991 |
Neuroleptic malignant syndrome (a case report).
Topics: Adult; Bromocriptine; Female; Haloperidol; Humans; Lorazepam; Neuroleptic Malignant Syndrome | 1991 |
Crossover reaction between haloperidol and amoxapine for NMS.
Topics: Aged; Amoxapine; Depressive Disorder; Dose-Response Relationship, Drug; Drug Therapy, Combination; F | 1991 |
NMS and haloperidol.
Topics: Dose-Response Relationship, Drug; Haloperidol; Humans; Infusions, Intravenous; Neuroleptic Malignant | 1991 |
Low melanin content of substantia nigra in a case of neuroleptic malignant syndrome.
Topics: Adult; Haloperidol; Humans; Male; Melanins; Methotrimeprazine; Neuroleptic Malignant Syndrome; Neuro | 1991 |
Psychogenic catatonia with elevated creatine kinase and autonomic hyperactivity.
Topics: Adult; Arousal; Autonomic Nervous System; Catatonia; Combined Modality Therapy; Creatine Kinase; Del | 1991 |
Neuroleptic malignant syndrome during abrupt reduction of neuroleptic treatment.
Topics: Adolescent; Antipsychotic Agents; Chlorpromazine; Dose-Response Relationship, Drug; Drug Therapy, Co | 1990 |
Neuroleptic malignant syndrome with renal and respiratory complications--a case report.
Topics: Acute Kidney Injury; Antipsychotic Agents; Female; Haloperidol; Humans; Neuroleptic Malignant Syndro | 1990 |
[Neuroleptic malignant syndrome].
Topics: Adult; Biperiden; Chlormethiazole; Chlorpromazine; Dantrolene; Diazepam; Female; Haloperidol; Humans | 1990 |
Porcine stress syndrome: an animal model for the neuroleptic malignant syndrome?
Topics: Animals; Brain; Bromocriptine; Disease Models, Animal; Haloperidol; Halothane; Hyperthermia, Induced | 1990 |
Neuroleptic malignant syndrome (NMS): challenge with zuclopenthixol and follow-up--a case report.
Topics: Adult; Clopenthixol; Dyskinesia, Drug-Induced; Electroencephalography; Female; Haloperidol; Humans; | 1990 |
Combined neuroleptic malignant syndrome and the central anticholinergic syndrome.
Topics: Adult; Benztropine; Bipolar Disorder; Coma; Diagnosis, Differential; Drug Therapy, Combination; Halo | 1990 |
EPS, NMS, and AIDS.
Topics: Adult; AIDS Dementia Complex; Atrophy; Cerebral Cortex; Dyskinesia, Drug-Induced; Haloperidol; Human | 1990 |
[Protracted recurrent neuroleptic malignant syndrome].
Topics: Adult; Bromocriptine; Dantrolene; Dose-Response Relationship, Drug; Female; Haloperidol; Humans; Neu | 1990 |
The neuroleptic malignant syndrome.
Topics: Adult; Female; Haloperidol; Humans; Metoclopramide; Neuroleptic Malignant Syndrome; Postoperative Co | 1990 |
Neuroleptic malignant syndrome.
Topics: Adult; Bromocriptine; Chlorpromazine; Dantrolene; Female; Haloperidol; Humans; Lithium; Neuroleptic | 1990 |
Neuroleptic-induced catatonia or a mild form of neuroleptic malignant syndrome?
Topics: Adult; Catatonia; Diagnosis, Differential; Haloperidol; Humans; Injections, Intramuscular; Male; Neu | 1990 |
Neuroleptic malignant syndrome with intravenous haloperidol.
Topics: Adult; Haloperidol; Humans; Male; Neurocognitive Disorders; Neuroleptic Malignant Syndrome; Psychomo | 1990 |
Treatment of lethal catatonia with electroconvulsive therapy and dantrolene sodium: a case report.
Topics: Adolescent; Catatonia; Combined Modality Therapy; Dantrolene; Diazepam; Electroconvulsive Therapy; H | 1990 |
Neuroleptic malignant syndrome.
Topics: Amylases; Haloperidol; Humans; Lipase; Male; Middle Aged; Neuroleptic Malignant Syndrome; Schizophre | 1988 |
[Severe late dyskinesia caused by neuroleptics in a young female. Follow-up and treatment].
Topics: Adolescent; Carbamazepine; Clozapine; Diagnosis, Differential; Dose-Response Relationship, Drug; Dru | 1989 |
Neuroleptic malignant syndrome associated with basal ganglia hemorrhage.
Topics: Aged; Basal Ganglia; Basal Ganglia Diseases; Cerebral Hemorrhage; Dementia; Haloperidol; Humans; Mal | 1989 |
Neuroleptic malignant syndrome in a trauma patient: case report.
Topics: Adult; Craniocerebral Trauma; Haloperidol; Humans; Male; Multiple Trauma; Neuroleptic Malignant Synd | 1989 |
Haloperidol-induced neuroleptic malignant syndrome in a 67-year-old woman with parkinsonism.
Topics: Aged; Female; Haloperidol; Humans; Lorazepam; Neuroleptic Malignant Syndrome; Parkinson Disease | 1989 |
The neuroleptic malignant syndrome and pneumomediastinum.
Topics: Adult; Chlorpromazine; Haloperidol; Humans; Male; Mediastinal Emphysema; Neuroleptic Malignant Syndr | 1989 |
Neuroleptic malignant syndrome in a case of post-partum psychosis.
Topics: Adult; Chlorpromazine; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Therapy, Comb | 1989 |
Neuroleptic malignant syndrome in the multiple trauma patient.
Topics: Adult; Creatine Kinase; Diagnosis, Differential; Haloperidol; Humans; Male; Multiple Trauma; Neurole | 1989 |
Recurrent neuroleptic malignant syndrome due to haloperidol and amantadine.
Topics: Aged; Amantadine; Dementia; Drug Therapy, Combination; Haloperidol; Humans; Male; Neuroleptic Malign | 1989 |
Neuroleptic malignant syndrome in an AIDS patient.
Topics: Acquired Immunodeficiency Syndrome; Adult; Haloperidol; Humans; Male; Neurocognitive Disorders; Neur | 1989 |
Neuroleptic malignant syndrome with hypomania and mental retardation.
Topics: Adult; Bipolar Disorder; Diagnosis, Differential; Haloperidol; Hepatitis B; Humans; Intellectual Dis | 1989 |
Neuroleptic malignant syndrome: three episodes with different drugs.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Female; Haloperidol; Humans; Neuroleptic Malignant Synd | 1986 |
Prevalence of neuroleptic malignant syndrome.
Topics: Antipsychotic Agents; Haloperidol; Humans; Neuroleptic Malignant Syndrome | 1987 |
Protracted neuroleptic malignant syndrome complicating long-acting neuroleptic administration.
Topics: Adult; Antipsychotic Agents; Delayed-Action Preparations; Enterocolitis, Pseudomembranous; Haloperid | 1988 |
Central dopaminergic and noradrenergic receptor blockade in a patient with neuroleptic malignant syndrome.
Topics: Clomipramine; Female; Haloperidol; Humans; Middle Aged; Neuroleptic Malignant Syndrome; Receptors, A | 1986 |
Neuroleptic malignant syndrome in an elderly patient.
Topics: Aged; Aged, 80 and over; Haloperidol; Humans; Male; Neuroleptic Malignant Syndrome | 1988 |
Neuroleptic malignant syndrome--a study of 4 cases.
Topics: Adult; Autonomic Nervous System Diseases; Female; Fluphenazine; Haloperidol; Humans; Male; Neurolept | 1988 |
"At risk" group for neuroleptic malignant syndrome.
Topics: Adult; Depressive Disorder; Haloperidol; Humans; Male; Neuroleptic Malignant Syndrome; Risk Factors | 1988 |
Neuroleptic malignant syndrome.
Topics: Child; Female; Haloperidol; Humans; Neuroleptic Malignant Syndrome | 1988 |
Agitation associated with dementia: neuroleptic malignant syndrome and fatal outcome in an 84-year-old man.
Topics: Aged; Aged, 80 and over; Dementia; Dose-Response Relationship, Drug; Haloperidol; Humans; Male; Neur | 1988 |
Neuroleptic malignant syndrome in a man with mental retardation.
Topics: Adult; Haloperidol; Humans; Intellectual Disability; Male; Neuroleptic Malignant Syndrome; Schizophr | 1988 |
Neuroleptic malignant syndrome presenting as adult respiratory distress syndrome and disseminated intravascular coagulation.
Topics: Diagnosis, Differential; Disseminated Intravascular Coagulation; Haloperidol; Humans; Male; Middle A | 1988 |
Haloperidol in neuroleptic malignant syndrome.
Topics: Dose-Response Relationship, Drug; Haloperidol; Humans; Neuroleptic Malignant Syndrome; Risk Factors | 1988 |
[Neuroleptic malignant syndrome after brief neuroleptic treatment].
Topics: Aged; Haloperidol; Humans; Lithium; Male; Neuroleptic Malignant Syndrome | 1988 |
Withdrawal NMS after drug treatment.
Topics: Amitriptyline; Drug Therapy, Combination; Haloperidol; Humans; Imipramine; Neuroleptic Malignant Syn | 1988 |
[A case report of death from neuroleptic malignant syndrome].
Topics: Adult; Cause of Death; Clomipramine; Haloperidol; Humans; Male; Neuroleptic Malignant Syndrome | 1988 |
Neuroleptic malignant syndrome or lithium neurotoxicity?
Topics: Drug Synergism; Haloperidol; Humans; Lithium; Neuroleptic Malignant Syndrome | 1987 |
Neuroleptic malignant syndrome.
Topics: Adult; Female; Haloperidol; Humans; Hysterectomy; Hysterectomy, Vaginal; Neuroleptic Malignant Syndr | 1986 |
Neuroleptic malignant syndrome responsive to carbidopa/levodopa: support for a dopaminergic pathogenesis.
Topics: Adult; Carbidopa; Drug Combinations; Haloperidol; Humans; Levodopa; Male; Neuroleptic Malignant Synd | 1987 |
The neuroleptic malignant syndrome (N.M.S.) in a West Indian of African descent.
Topics: Adult; Africa; Female; Haloperidol; Humans; Neuroleptic Malignant Syndrome; Schizophrenia; Trinidad | 1987 |
Neuroleptic malignant syndrome.
Topics: Bipolar Disorder; Female; Haloperidol; Humans; Middle Aged; Neuroleptic Malignant Syndrome | 1986 |
Neuroleptic malignant syndrome successfully treated with amantidine.
Topics: Adult; Amantadine; Female; Haloperidol; Humans; Neuroleptic Malignant Syndrome | 1986 |
[Neuroleptic malignant hyperthermia syndrome].
Topics: Adult; Female; Haloperidol; Humans; Neuroleptic Malignant Syndrome | 1986 |
Neuroleptic malignant syndrome in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Haloperidol; Humans; Male; Neuroleptic Malignant Syndrome; Risk | 1986 |
Possible central effect of dantrolene sodium in neuroleptic malignant syndrome.
Topics: Brain; Dantrolene; Female; Haloperidol; Humans; Middle Aged; Neuroleptic Malignant Syndrome; Psychot | 1986 |
Relationship between neuroleptic malignant syndrome and malignant hyperthermia.
Topics: Atracurium; Basal Ganglia Diseases; Depressive Disorder; Electroconvulsive Therapy; Haloperidol; Hum | 1985 |
[Neuroleptic malignant syndrome and myopathy: a case report of lithium and haloperidol intoxication].
Topics: Adult; Female; Haloperidol; Humans; Lithium; Muscular Diseases; Neuroleptic Malignant Syndrome | 1985 |
Resolution of neuroleptic malignant syndrome with dantrolene sodium: case report.
Topics: Basal Ganglia Diseases; Bipolar Disorder; Dantrolene; Drug Therapy, Combination; Haloperidol; Humans | 1985 |
A role for catecholamines in the pathogenesis of neuroleptic malignant syndrome.
Topics: Akathisia, Drug-Induced; Brain Chemistry; Catecholamines; Chlorpromazine; Haloperidol; Humans; Imipr | 1986 |
Neuroleptic malignant syndrome complicating closed head injury.
Topics: Adult; Brain Injuries; Bromocriptine; Haloperidol; Humans; Male; Neuroleptic Malignant Syndrome; Psy | 1986 |
[Malignant neuroleptic syndrome: successful treatment of a patient with bromocriptine].
Topics: Adolescent; Basal Ganglia Diseases; Bromocriptine; Haloperidol; Humans; Male; Neuroleptic Malignant | 1985 |
Atypical neuroleptic malignant syndrome responsive to conservative management.
Topics: Adult; Basal Ganglia Diseases; Cryotherapy; Fluid Therapy; Haloperidol; Humans; Male; Neuroleptic Ma | 1985 |
Pridinolum mesylate and neuroleptic malignant syndrome.
Topics: Adult; Basal Ganglia Diseases; Delusions; Haloperidol; Humans; Male; Neuroleptic Malignant Syndrome; | 1985 |
Neuroleptic malignant syndrome.
Topics: Adult; Basal Ganglia Diseases; Bromocriptine; Dantrolene; Diagnosis, Differential; Haloperidol; Heat | 1985 |
Neuroleptic malignant syndrome: successful treatment with bromocriptine.
Topics: Adolescent; Basal Ganglia Diseases; Bromocriptine; Creatine Kinase; Haloperidol; Homovanillic Acid; | 1985 |
[Malignant neuroleptic syndrome and biperiden].
Topics: Biperiden; Haloperidol; Humans; Male; Middle Aged; Neuroleptic Malignant Syndrome; Piperidines | 1985 |
Neuroleptic therapy following neuroleptic malignant syndrome.
Topics: Adult; Drug Therapy, Combination; Haloperidol; Humans; Male; Neuroleptic Malignant Syndrome; Perphen | 1985 |